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ABSTRACT

Estrogen Modulation of VTA Dopamine Neuron Physiology and Behavioral Responsivity to
Variable Social Stressors
By
Mary Regis Shanley
Advisor: Allyson K. Friedman

The behavioral output of different animals, or even the same animal in different contexts,
is remarkably variable in response to the same external stimulus. This behavioral diversity is due
to the complex integration of external and internal stimuli, through both neuronal and hormonal
signals that selects the best behavioral response. By their nature as long-distance signaling
molecules, hormones play a critical role in communicating information about internal states
across the organism. Many hormones produced in the periphery target the central nervous system
to modulate animal behavior, selecting for behaviors that are appropriate over behaviors that are
maladaptive in that specific situation. These hormones generally communicate the internal state
of the organism, such as reproductive status, or stress.
Sex steroid hormones are a diverse class of hormones that include estrogens,
progestogens, and androgens. These hormones are released from the gonads and act on the brain
to control a range of behaviors s involved in reproduction. Decades of research demonstrate both
short- and long-term actions of these signaling molecules that directly affect the physiology of
iv

neurons in various regions of the brain. In addition to brain regions controlling behaviors
involved in reproduction, these changes have also been found in regions important for
controlling non-reproductive behaviors, such as memory, cognition, and motivation.
Estrogens are a class of steroid hormones that activate estrogen receptors (ERs) and have
a strong influence on neuronal activity throughout the brain and periphery. While estrogens are
typically associated with the female reproductive cycle, more than 50 years of research shows
that ERs are expressed throughout the brain in both sexes and modulate behavior and cognition
not typically associated with reproductive behavior, such as memory and motivation. Moreover,
estrogen signaling has a role in modulating motivation and mood in humans, non-human
primates, and rodents, indicating a conserved role for estrogen signaling across species. The
ventral tegmental area (VTA) is a dopaminergic nucleus in the midbrain that is associated with
motivation is also highly conserved across species. Shifting of motivation through modulation of
the dopaminergic hub of the brain is important for behavioral plasticity that determines an
appropriate behavioral response based on the external and internal environment.
Motivation refers to the drive to perform a behavior to obtain a goal (Simpson and
Balsam, 2016). Strong primary motivations include obtaining food and shelter, finding a mate to
reproduce, or avoiding dangerous situations. Motivated behaviors are triggered by an external
event, such as a reward or a cue paired a reward. The behavioral response to a motivating cue is
also modified by an internal state. Classic in vivo recordings of dopamine neurons in the VTA
show increases in firing rate in response to both rewarding and aversive external stimuli. These
responses are not limited to the reward or aversive stimuli, but also with neutral stimuli that have
been paired with the reward or punishment. Research has revealed that the reward system,
including the VTA, is modulated by estrogen signaling. However, much of the research in this
v

area focuses on the effects of estrous cycle and estrogen signaling in regions that receive
projections from the VTA, such as the striatum, the hippocampus, and the prefrontal cortex,
while little research exists examining the role of estrogen in directly modulating the physiology
of dopamine neurons in the VTA.
Motivation is a component of mood, and a change in motivation to obtain reward is a
hallmark of mood disorders such as depression. Women are up to twice as likely to be diagnosed
with major depressive disorder (MDD) than men (Noble, 2005). In many women, changes in the
menstrual cycle can lead to changes in mood and motivation. Several depressive disorders and
modifiers of MDD in the Diagnostic and Statistical Manual V (DSM-V) are associated with
fluctuations in hormones. These include premenstrual dysphoric disorder (PMDD), postpartum
depression, and mood changes during perimenopause. Moreover, depression treated with
medication can lead to changes in menstrual cycle length and regularity, suggesting an
interaction between mood and hormone fluctuations (Rowland et al., 2002). Additionally, rodent
models of stress susceptibility provide evidence that the dopaminergic response to stress is sexand hormone dependent.
In this dissertation, I will present experimental evidence that estrogen signaling in the
VTA is an important modulator of dopamine neuron physiology, which leads to differences in
the behavioral response to stress in female mice. I show that the physiology of dopamine neurons
in the VTA of female mice changes across the estrous cycle. These changes are at least partially
caused by changes in estrogen signaling, as shown by pharmacological manipulation of estrogen
signaling in in vitro slice preparation. Moreover, estrogen signaling in the VTA is involved in the
behavioral response to stress, as pharmacological manipulation of estrogen signaling in intact
female mice changes the behavioral response to stress.
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Chapter 1: Introduction
Hormones and mood have long been connected in human and animal behavior.
Specifically, hormonal fluctuations across a women’s life span have been deeply correlated with
alterations in mental health. For example, changes in hormone levels during the menstrual cycle
are associated with changes in mood, postpartum depression is directly linked to a rapid decline
in hormone levels after giving birth, and one of the main symptoms of menopause is rapid
changes in mood. However, the underlying ionic mechanisms of how hormone changes influence
mood remain understudied.
Steroid hormone signaling is a powerful modulator of the central nervous system.
Multiple brain regions express steroid receptors in the nucleus, cytosol and on the plasma
membrane. Steroid hormones are small, lipophilic molecules frequently associated with
reproduction (sex steroids such as estrogens, androgens, and progestogens) and stress
(glucocorticoids and mineralocorticoids). These systems are acutely interrelated, with sex
hormones influencing the stress response, and vice versa. The dopamine system, a critical
component of the behavioral response to stress, is also poised to be modulated by steroid
hormones. It serves as a primary site of integration between stress and steroid hormone signaling.
Specifically, estrogen signaling is likely to be important for the behavioral and physiological
changes across the female hormonal cycle. In this chapter, I will review what is known about
estrogen signaling in the brain, the behavioral and physiological response to stress in females,
and what is known about estrogen signaling in the ventral tegmental area (VTA), a dopaminergic
center that is known to be involved in regulating behavioral susceptibility and resilience to stress.

1

Part 1: Estrogen signaling in the brain: modulating neuronal physiology to influence
reproductive and non-reproductive behaviors.
The estrous cycle
Mice and rats are valuable animal models for neuroscience research due to their
physiological and genetic similarity to humans, wide range of social behaviors and accessibility
of research tools. In female mice, the estrous cycle is 4-5 days, which is analogous to the 28 day
long human menstrual cycle. This provides a temporally compressed and physiologically
relevant model system in which to study the role of estrogen fluctuations. Despite the genetic
similarities with humans, the rodent estrous cycle has some physiological differences. Mice do
not have a menses portion of their cycle where the uterine lining is shed. Mice are also
spontaneous ovulators and release many eggs at once (up to 10 per ovary), given that they have
multiple births (Rugh, 1968). Despite these differences, both processes share critical components
in which comparative research can reveal insight into molecular action of estrogen in the brain
(Figure 1.1). For example, in both humans and mice, estrogen levels peak at ovulation and
stimulate the release of one or multiple eggs from the mature follicle. This occurs at the end of
the follicular phase in women, and during the night of proestrus in mice. Estrogens are produced
in the ovaries by granulosa cells through the conversion of androgens by the enzyme aromatase.
Several different steroidal estrogens occur naturally, of which 17-β estradiol (E2) is the most
prevalent. Increased estrogen levels prepare the uterus for embryo implantation and result in the
maturation of egg follicles in the uterus. After the egg is released from the mature follicle, the
corpus luteum is formed. This structure is responsible for the post-ovulatory increase of
progesterone. In the uterus, this progesterone surge counteracts some of the effects of estrogen
on the uterus by reducing the expression of estrogen receptors (Hsueh et al., 1975).
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There are several challenges in monitoring the estrous cycle in mice. Vaginal cytology,
where a sample of cells collected from the vagina of a female rodent, is the gold standard for
monitoring estrous cycle. However, some studies have shown that even in well-trained
experimenters, there is high inter-rater variability due to the subjectivity of the prevalence of
different cell types in the sample (Gal et al., 2014). These problems can be mitigated by
increased training. Additionally, there is some concern with stressing females during swabbing
procedure or inducing pseudopregnancy through repeated cervical stimulation. However, this can
be circumvented with the correct swabbing technique and appropriate controls in all groups of
experimental subjects.
Determining estrous cycle based on biochemical markers is also challenging, since serum
estrogen levels are very low in mice, and are usually below the sensitivity of commercially
available ELISAs. Additionally, a relatively large volume of serum is needed for testing, which
is usually only obtained through transcardial collection, which is terminal. Some groups have
modified the commercially available kits to detect low ranges of 17-β estradiol (E2), the most
prevalent naturally circulating estrogen. However, the validity and sensitivity of these
modifications are debated (Gal et al., 2014). Mass spectrometry has also been used to measure
the levels of steroids hormones in mouse blood and serum, however, this technique is costly and
low throughput (Nilsson et al., 2015). More sensitive, lower cost technology is needed to detect
absolute levels of hormones from very small amounts of blood or serum.
A classical and sensitive bioassay for detection of estrogenic activity of a chemical
compound uses the natural response of the uterus of mice to increase in response to estrogen
receptor activation (Wang et al., 2016; Rugh, 1968). In this assay, experimental compounds are
deemed to be estrogenic if, when injected into the mouse, mimic the natural activity of estrogens
3

released by the ovaries. This results in a distinct increase in uterine weight and can also serve as
an extremely sensitive readout of estrogen levels that may be lower than can be detected by
ELISA measurements (Rugh, 1968; Jensen, 1962). However, this readout of hormone levels is
only feasible in terminal experiments, which precludes the use of this method for longitudinal
studies of the effects of the estrous cycle on behavior, for example. Utilizing a combination of
methods to determine estrous cycle continues to be a valuable approach.
While the estrous cycle is a valuable physiological process to research for breeding
purposes, it also provides an opportunity to study the role of steroid signaling in the central
nervous system. In humans and in rodents, steroid hormones released from the ovaries and testis
also travel through the bloodstream to exert feedback on the brain to control the cycle itself, but
also to control behaviors related to reproduction, such as seeking a suitable mate (Banks, 2012;
Schlinger et al., 2014). Therefore, steroids produced in the periphery have direct access to the
neurons in the brain and can influence the physiology of circuits that express receptors for these
molecules. Steroids are also made de novo in the brain and can have local effects independent
from the estrous cycle (Schlinger et al., 2014).
Frequently, a reductionist method of using gonadectomy to control the levels of
hormones is performed to examine this complex system. However, the removal of all steroid
hormone production can cause unintended widespread changes in response to the deprivation of
natural levels of peripheral steroid hormones, such as changes in metabolism and changes in the
behavioral response to stress (Levin, 2009, Lagunas et al., 2010). Removing this natural
phenomenon may therefore result in an incomplete analysis of this complex system. Further
experimental approaches of controlled hormone replacement have provided insight but are still
fraught with questions of hormone interactions and withdrawal states.
4

The “basics” of estrogen signaling at the cellular level
The cellular response to estrogen signaling depends on the cell-type and, more
specifically, the molecular machinery present in the cell. This response usually starts with the
activation of estrogen receptors (ERs), and results in various downstream effects, including
changes in transcription of gene targets, activation of second messenger systems, and direct
modulation of ion channels, resulting in diverse physiological effects in the presence of estrogen.
Three ERs have been cloned and described, and a fourth has been pharmacologically identified:
the “classical” Estrogen Receptor (ER)α and ERβ, as well as the G protein coupled receptor
GPR30/GPER, and a membrane-associated ER that responds to the selective agonist STX,
known as Gq-coupled membrane associated estrogen receptor (Gq-mER). Each receptor is
involved in a multitude of pathways through which they exert their effects on neuronal
excitability.
ERα and ERβ are considered “classical” ERs, such that they act as transcription factors
when they are activated. ERs are released from heat shock proteins in the cytoplasm and move to
nucleus and activate or inhibit the transcription of genes with estrogen responsive elements.
Many of these genes are ion channels, making estrogen a potent regulator of neural activity
(Kow and Pfaff, 2016).
Rapid effects of ERα and ERβ are regularly observed that are too fast for protein
synthesis dependent pathways. Many of these rapid effects are membrane associated since
membrane-impermeable BSA-conjugated E2 activates these effects, despite being membrane
impermeable. Since these experiments, it has been well established that ERα and ERβ are
frequently localized to the cell membrane through palmitoylation modifications, where they
interact with caveolin proteins and other molecules to form complex signaling structures that
5

lead to rapid activation of signaling cascades (Levin, 2009). Detection of membrane associated
receptors is difficult using immunofluorescence techniques; electron microscopy has detected
ERα expression in axons and axon terminals in the hippocampus (Milner et al., 2001).
The specific effects of ERα and ERβ can be dissociated though the use of agonists and
antagonists that are specific to the receptor types. Though research targeting these receptors for
ER+ breast cancer treatment, antagonists specific to estrogen signaling potently reduce the
effects of ERα and ERβ. One such drug, ICI 182,780 is specific to ERs, but non-specific in the
sense that it inhibits both ERα and ERβ. Other drugs, such as Methyl-Piperidinopyrazole (MPP)
and 4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol (PHTPP)
specifically inhibit ERα and ERβ, respectively, although at high concentrations may have cross
reactivity.
Knockout mouse models have also been developed for both ERα and ERβ (Walker and
Korach, 2004). Both knockout lines show striking behavioral differences in social behavior
compared to wildtype littermate controls. Male ERα knockout mice show a decrease in
aggression towards a male intruder (Ogawa et al., 1997). Interestingly, female ERα knockout
mice showed an increase in aggression towards a female intruder mouse (Ogawa et al., 1998).
ERα knockout mice also showed a deficit in social discrimination, a widely-used behavioral
paradigm where the time spent with a novel mouse is compared to time spent with a familiar
conspecific (Choleris et al., 2003; Choleris et al., 2006). In wild-type rodents, a novel social
target is investigated more than a familiar target, whereas in ERα knockout animals spent equal
time investigating both novel and familiar targets. Male and female ERβ knockout mice show
increased anxiety related behaviors (Imwalle et al., 2005; Tomihara et al., 2009). ERβ knockout
mice also show a deficit in social discrimination, although to a lesser extent than ERα knockout
6

mice (Choleris et al., 2006). The diversity in behavioral responses, with at times opposing action
of the same ER, suggests that ERα and ERβ are deeply involved in modulating social behaviors,
and that ER action on behavior is both highly sex and stage of estrous dependent.
In addition to the rapid effects of classical ERs, a G protein coupled ER (GPER) has been
identified that rapidly effects neuronal excitability upon binding with estrogen (Revankar et al.,
2005). This transmembrane receptor is localized to the endoplasmic reticulum (Hazell et al.,
2009). Activation of this receptor has been shown to increase the release of internal calcium
stores from the endoplasmic reticulum, activate IP3, and modulate other calcium signaling
pathways. Additionally, GPER activation can cause changes in CREB signaling, which leads to
changes in transcription levels of responsive genes, including ion channels. Unlike the other ERs,
the drug ICI 182,780 acts as an agonist for GPER rather than an antagonist (Long et al., 2017).
A fourth ER, known as the Gq-coupled membrane associated estrogen receptor (GqmER) is a recently described membrane associated ER that is activated by the non-steroidal
molecule STX (Vail and Roepke, 2019). Much less is known about this receptor than the other
three identified types, especially since the sequence and structure are unknown. However, it has
become clear that this receptor has a role in neuronal excitability, especially in energy
homeostasis in the hypothalamus, since E2 as well as the selective agonist, STX, prevents excess
body weight gain in ovariectomized mice and guinea pigs (Qiu et al., 2006). STX disinhibits
POMC neurons in wild type as well as ERα and ERβ knockout mouse lines. The non-selective
ER antagonist, ICI 182,780 is also effective in inhibiting the effects of this receptor, as well as
the effects of ERα and β (Qiu et al., 2003, Qiu et al, 2006).

7

Ion channel targets of estrogen signaling are expressed in the VTA
The physiology of dopamine neurons in the VTA has been extensively studied to gain
better understanding of disorders of the dopamine system, including addiction, mood disorders,
and movement disorders such as Parkinson’s disease. Dopamine neurons exhibit a regular,
pacemaker-like firing pattern in both in vivo and in slice preparations in the absence of synaptic
input. The currents driving and modulating this activity include hyperpolarization currents (Ih),
various potassium currents, including M-type, A-type, and inwardly rectifying currents, and
calcium currents. These currents are modulated by estrogen signaling in other regions of the
brain (Kow and Pfaff, 2016). The effects of estrogen on these currents are cell-type and brain
region specific and can be opposite, depending on the internal hormonal state and experimental
conditions. Estrogen signaling can also affect components of synaptic signaling, including
metabotropic glutamate receptors (mGluRs), and dopamine transporter (DAT) and dopamine
receptors, all of which play a critical role in the activity of dopamine neurons in the VTA.
Despite the breadth of research on physiological effects of estrous cycle at the cellular
level in other brain regions, a detailed analysis of its role and mechanism of action in the ventral
tegmental area is limited. Therefore, to provide context to the scope of estrogen’s action on
neural activity, this section introduces the ion channels and the corresponding currents known to
be modulated by estrogen signaling in other regions of the brain. These currents have also been
identified in dopamine neurons in the VTA and I propose that similar mechanisms are at play in
estrogenic modulation of VTA physiology (Table 1.1).
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels: HCN channels are
responsible for a current induced by hyperpolarizing the cell (I h). In combination with other ion
channels, HCN channels regulate the resting membrane potential and intrinsic excitability of the
8

soma, and have a role in synaptic integration depending on the expression pattern in the dendrites
(Kase and Imoto, 2012). These channels are comprised of different subunits, termed HCN1-4,
expression of which determines the kinetics of Ih and their sensitivity to cyclic nucleotides
(Noam et al., 2011).
The presence of Ih is largely considered to be a marker of dopamine neurons in the VTA
(Grace and Onn, 1989). In dopamine neurons, Ih is partially responsible for repolarizing the cell
membrane after an action potential. Increased conductance of HCN channels can lead to an
increase in spontaneous firing rate and intrinsic excitability since the membrane is repolarized
faster with these channels open (Neuhoff, Neu, et al., 2002). However, there is also considerable
variability of Ih amplitude within dopamine neurons from the same animal, depending on their
medio-lateral location within the VTA, their projection targets, and sub-population (Zhang et al.,
2010).
In GnRH neurons, expression of the HCN1, but not HCN2 subunit is increased in
response to E2 treatment in ovariectomized females (Ronnekleiv et al., 2015; Bosch et al. 2013).
Increased HCN1 expression leads to an increase in bursting activity in GnRH neurons. While
increases in HCN2 channel subunit expression in the VTA is associated with increased stress
susceptibility, the HCN1 subunit is also expressed, and may contribute to fine-tuning the kinetics
of the hyperpolarization current (Zhong et al., 2017).
KCNQ channels: KCNQ type channels are potassium channels that are responsible for
the M-type potassium currents, and are characterized by large, non-inactivating outward currents.
Since these channels are activated at membrane potentials near rest, M-type currents can act as a
shunt, reducing intrinsic excitability by counteracting the inward sodium current. These channels
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can be blocked by the drug XE991 to reveal the contribution to the rebound after a spontaneous
action potential (Koyama and Appel, 2006).
Like many potassium channels, KCNQ channels are the target of modulation by drugs
and by experience, which leads to changes in behavior. For example, ethanol exposure reduces
the current through KCNQ channels, resulting in an increase in excitability (Koyama et al.,
2007). KCNQ channels are also important for stress susceptibility and resilience, and
pharmacologically activating KCNQ channels promotes behavioral resilience to stress in male
mice (Friedman et al., 2016). Since ethanol drinking and the behavioral response to stress are
both modulated by estrogen signaling, KCNQ channels on dopamine neurons are potential sites
of integration for these signals (Satta et al., 2018; Palanza et al., 2001; ter Horst et al., 2013;
Trainor et al., 2013).
KCNQ channels are responsible for M-type potassium currents, which are modulated by
estrogen signaling in several different populations of neurons in the hypothalamus. In females
treated with E2 injections, the M-type potassium current in hypothalamic neuropeptide Y
neurons is significantly higher than females treated with oil (Roepke et al., 2011). This results in
a decrease in activity in these neurons, and suppression of feeding behavior. If estrogen signaling
leads to similar effects in VTA dopamine neurons as in NPY neurons in the hypothalamus, an
increase in estrogen signaling would lead to a decrease in intrinsic excitability, as well as an
increase in potassium currents evoked by a sustained depolarizing voltage.
Small-conductance potassium (SK) channel: Small-conductance potassium channels (SK)
are calcium activated potassium channels that are activated by raised levels of intracellular
calcium through voltage-gated calcium channels (Faber and Sah, 2007). SK channels are
typically associated with the shape of the afterhyperpolarization after an action potential. In
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dopamine neurons, SK channels are involved in regulating pacemaker activity during
spontaneous activity, as well as the switch between pacemaker activity and burst firing modes
(Wolfart et al., 2001). Blocking these currents with apamin increases variability in spontaneous
activity in slice preparations and sometimes induces burst firing patterns that are not usually
observed in slice (Philippart et al., 2016).
SK channels are also expressed in GnRH neurons in the hypothalamus. In this population
of neurons, increased E2 levels lead to a decrease in transcription of SK3 (Bosch et al., 2013).
This change in SK channel expression has been implicated in the reduction of the amplitude of
the afterhyperpolarization after treatment with E2, which would allow for the neuron to
repolarize faster and increase the firing rate of the neuron.
SK channels are also typically associated with calcium channels, which supply the SK
channels with the calcium signal needed to initiate opening. Some voltage-gated calcium
channels are subject to modulation by estrogen signaling. Estrogen signaling reduces L-type
calcium currents in rat medium spiny neurons in the dorsal striatum (Mermelstein et al., 1996).
Estrogenic modulation of these calcium currents could cause indirect modulation of SK
channels.
In dopamine neurons in the VTA of male rats, L-type calcium currents are small relative
to nearby dopamine neurons in the substantia nigra but still comprise a significant component of
the total calcium current (Philippart et al., 2016). Interestingly, blocking the L-type calcium
current reverses the increase in variability induced by treatment with apamin, suggesting that Ltype calcium currents are responsible for inducing the variability in firing caused by SK channel
activity reduction (de Vrind et al., 2016). Increases in variability in spontaneous firing rates in
VTA dopamine neurons across the estrous cycle would suggest a decrease in SK currents or L11

type calcium currents. Since increased bursting has been observed in vivo during estrus, when
measured estrogen levels are high but dropping, a reduction in SK channel activity during this
time may be responsible for an increase in firing rate variability and bursting activity.
Big conductance potassium (BK) current: BK channels, also known as maxi-K channels,
are responsible for large, voltage and calcium-activated potassium currents. Inhibition of BK
channels in VTA dopamine neurons results in a wider action potential and a more negative
afterhyperpolarization after an action potential (Kimm et al., 2015). BK channel inhibition
reduces the intrinsic excitability of dopamine neurons by slowing the afterhyperpolarization and
leading to the activation of potassium currents with slower inactivation (Kimm et al., 2015). BK
channels, therefore, may have a role in allowing the neuron to increase bursting by repolarizing
faster (Gantz et al., 2018). Physiological concentrations of estrogens activate BK channels in
muscle cells and neurons (Kow and Pfaff, 2016). The β1 subunit of the BK channel has a binding
site for estrogen, which means that estrogen modulate the activity of BK channels in the absence
of ERs (Valverde et al., 1999)
NALCN: The sodium leak channel, nonselective (NALCN) is a leak channel that is
expressed in neurons throughout the brain. NALCN is responsible for a sodium leak current that
contributes to the pacemaker firing pattern of dopamine neurons in the VTA (Khaliq and Bean,
2010). This leak current is responsible for the maintenance of spontaneous activity, since
dopamine neurons in NALCN knockout mice are more likely to be silent (Philippart and Khaliq,
2018). Moreover, NALCN is inhibited by D2 receptor activation in VTA dopamine neurons
(Philippart and Khaliq, 2018). This results in a reduction of firing rate that is independent from
other mechanisms of D2 receptor inhibition of neuronal activity, such as G-protein inwardly
rectifying potassium channel activation (Philippart and Khaliq, 2018).
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Recently, progesterone and E2 have been shown to change transcription of NALCN in
the myometrial layer of human uterine tissue (Amazu et al., 2020). E2 and progesterone also had
effects on NALCN currents in these cells, with E2 inhibiting the current and progesterone
enhancing it (Amazu et al., 2020). It has not yet been explored whether estrogen and
progesterone have similar effects in neurons in the central nervous system. However, if estrogen
signaling inhibits NALCN in a similar manner in dopamine neurons in the VTA, this would
likely lead to slowing of spontaneous firing (Philippart and Khaliq, 2018).
Part 2: The role of dopamine in the behavioral response to stress
Research in animal models of stress-related disorders have revealed that the VTA activity
is linked to disruptions in healthy behaviors (Russo and Nestler, 2013). Although more women
than men are diagnosed with depression and anxiety, most of this research has been done
exclusively in male animals without the consideration of the role of the estrous cycle or sex
steroid hormones. This section will focus on what is currently known about the role of the VTA
from the research in males, as well as some of what has recently been uncovered about the
changes in the dopamine system in response to stress in females.
The physiology of the ventral tegmental area is linked causally with the behavioral
outcome after chronic social defeat stress in males
Chronic social defeat stress (CSDS) is a mouse model of depression that uses the innate
territorial response of male mice to induce depression-like behaviors. In this model, many mice
develop depression-like behaviors, such as social avoidance and anhedonia, whereas a subpopulation displays control-like behaviors (Krishnan et al., 2007). These groups are referred to as
“susceptible” and “resilient”, respectively. These two groups show distinct changes in the
physiology of dopamine neurons in the VTA after stress. In all stressed animals, dopamine
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neurons show a significant increase in Ih mediated by an increase in HCN channels (Cao et al.,
2010; Zhong et al., 2017; Ku and Han, 2017). In susceptible animals, this increase in I h results in
an increase in intrinsic excitability and spontaneous firing rate, compared to non-stressed
controls. In resilient animals, however, this increase in Ih is balanced by an increase in potassium
currents through KCNQ channels, resulting in a spontaneous firing rate and intrinsic excitability
that is similar to that of controls (Friedman et al., 2016). By increasing IK+ in susceptible animals,
the behavioral phenotype can be switched from susceptible to resilient (Friedman et al., 2016).
However, since this paradigm relies on aggression behavior that is not naturally displayed in
female mice, this phenomenon has been understudied in females. Since many of the ion channels
that are involved in the resilience process in males are also targets of estrogen signaling in other
regions of the brain, I hypothesize that estrogen signaling modulates the dopamine system to
modify the behavioral response to stress.
Sex differences in the physiology of VTA dopamine neurons after stress
In humans, symptoms of stress-related mental disorders are well known to be modified
by the menstrual cycle (Rowland et al., 2002). Manipulations of hormones using birth control
can cause severe swings in mood, leading to termination of usage (Poromaa and Segebladh,
2011). Women tend to have higher baseline levels of the stress steroid hormone, cortisol, and
release more in response to stressful events (Kirschbaum et al., 1992). Additionally, sex
differences in multiple mood disorders emerge during puberty, postpartum, and during
menopause, all periods of extreme fluctuations in sex steroid hormones (Altemus, 2006). These
observations in humans provide indirect evidence that stress and sex steroid hormones interact in
some way with the dopamine system to modulate mood. However, whether these effects of
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steroid hormones have a direct effect through actions in the VTA has not been explored in rodent
models.
Although CSDS is not a reliable model of depression in female mice due to their low
levels of aggression, a different rodent model may provide some information on the response of
VTA dopamine neurons in response to social stress. Female California mice show aggression
towards a female intruder, and so can be used in the CSDS paradigm (Holly and Miczek, 2016)
in both sexes. In a shorter, 3-day paradigm, one group observed an increase in the number of
dopamine neurons, identified by tyrosine hydroxylase (TH), that colocalize with the immediate
early gene, c-fos, in stressed females but not stressed males, suggesting an increase in neuronal
activity in VTA dopamine neurons after stress, similar to what is seen in male mice after 10 days
of CSDS. Interestingly, in this paradigm, females show changes in VTA dopamine neuron
activity after only 3 days of stress, compared to 10 days in male California mice and male lab
mice, suggesting that females have a lower threshold for the impact of CSDS than males
(Greenberg et al., 2015). In this study, the authors also found a significant effect of sex on the
number of TH+/c-fos+ cells, with females having more colocalizations than males, regardless of
stress, suggesting that dopamine neurons are generally more active in female California mice.
There are several criticisms of the ethological and translational validity of CSDS in
females (Solomon, 2017). In humans, the behavioral response to sustained aggression has been
well studied, and men and women tend to have very different responses, with men displaying
externalizing behaviors (aggression, vandalism, theft, etc.), and women displaying internalizing
behaviors (social withdrawal, depression, anxiety, etc.) (Solomon, 2017). After CSDS, male
mice and rats tend to display internalizing behaviors as measured by a decrease in social
interaction, decrease in sucrose preference, and an increase in anxiety. Additionally, social
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avoidance after repeated aggression could also be interpreted as an adaptive response to an
aggressive conspecific, where the experimental mouse has, understandably, learned that social
interactions are risky and should be avoided (Solomon, 2017). In this interpretation, the resilient
animals show a deficit in social learning, whereas susceptible animals show an adaptive response
to an aggressive social interaction.
An alternative stress paradigm, called unpredictable mild stress (UMS), avoids some of
these issues. This stress can be used easily in male and female laboratory mice, since the
stressors include physical stressors such as tail suspension and foot shock instead of relying on
sex specific aggression behaviors. When female mice are exposed to UMS, they show an
increase in time spent immobile in a forced swim test compared to males (Rincon-Cortes and
Grace, 2017). Importantly, there are few behavioral differences between unstressed males and
females, suggesting that a challenge (i.e. drug or stress) more easily perturbs the female VTA
(Rincon-Cortes and Grace, 2017). However, the UMS paradigm varies between lab groups in
length and stressor types, making direct comparisons across groups difficult. One major theme
that emerges from the literature, however, is that females are more sensitive to stress, and show
behavioral changes earlier in the paradigm compared to males.
While the VTA does not display obvious sex differences in anatomy, several functional
differences in the VTA have been observed between males and females (Greenberg and Trainor,
2016). For example, larger amounts of dopamine are released from the axons of dopamine
neurons from the VTA in the NAc in females compared to males (Becker, 2009; Calipari and
Juarez et al., 2018). These observations seem to be driven, at least in part, by changes in release
across the estrous cycle, with the most dopamine released during estrus, when estrogen levels are
high but rapidly declining from their peak during proestrus the night before (Calipari and Juarez
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et al., 2018). These authors also observed an increase in bursting activity in VTA dopamine
neurons during estrus, as measured by in vivo electrophysiology. Additionally, dopamine
neurons in the VTA of females during estrus are more sensitive to the inhibitory effects of
dopamine during estrus (Vandegrift et al., 2017) While many of these experiments were
performed in the context of drug addiction, it would not be surprising to learn that the estrous
cycle modulates the sensitivity of dopamine neurons to stress in females, given the involvement
of the VTA in the male response to stress.
Part 3: Estrogenic modulation of the ventral tegmental area
Expression of estrogen receptors in the VTA
Activation of estrogen signaling pathways in many instances begins with estrogens
binding to an estrogen receptor. Although there are challenges with immunohistochemical
detection of ERs, several groups have established that a subset of neurons in the VTA express
ERs. The ERβ-eGFP BAC transgenic mouse line has been useful in characterizing the expression
patterns of ERβ+ cells (Milner et al., 2010). This transgenic line expresses GFP in cells that are
actively expressing ERβ. Many groups have observed expression of ERβ in the VTA of both
mice and rats (Milner et al., 2010; Creutz and Kritzer, 2002). In rats, the expression of ERβ
seems to be localized to specific projections, including VTA-PFC and VTA-amygdala
projections, but not VTA-NAc, although this study used antibodies against ERβ, not a transgenic
reporter (Kritzer and Creutz, 2004; Kritzer and Creutz, 2008). Additionally, the percentage of
overlap between ERβ+ cells and TH+ neurons is unknown, as is whether there are sex
differences in expression patterns.
The results of studies that localize ERα to dopamine neurons in the VTA are also
variable, as whole-brain analysis of ERα from several groups using different antibodies has
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produced conflicting results (Vandegrift et al., 2020; Mitra et al., 2003; Kritzer and Creutz,
2008). ERα expression is modulated by environmental factors, such as housing conditions,
which provides an additional explanation (Landeros et al., 2012). Also, examination of other
brain regions using electron microscopy has shown that expression of membrane associated ERs
in several brain regions is too low to detect with classical immunohistochemistry and confocal
microscopy methods, even though the receptors are present in the membrane (Milner et al., 2001;
Almey et al., 2014; Milner et al., 2005). Like ERβ, the quantification of the expression patterns
of ERα in the VTA, and what percentage of ERα+ cells in the VTA overlap with TH+ cells is
incomplete.
Because of the relatively recent discovery of GPER as an ER, much less has been
described about GPERs expression in the VTA. One whole-brain study using immunoreactivity
against GPER suggests that GPER is not expressed in the VTA (Hazell et al., 2009). However,
like many ERα and ERβ immunoreactivity experiments are qualitative, and compare expression
relative to brain regions that have very high expression levels. Another potential confound is the
use of rats in many of these studies. Potential differences in expression patterns of ERs between
mice and rats in the brain are not well investigated.
Since Gq-mER has only been identified pharmacologically, through responsiveness to the
selective agonist, STX, it has not been explored whether this receptor is expressed in the VTA.
This would have to be done using electrophysiology to probe whether there is an effect of STX
in the VTA. Since this drug is not yet commercially available, experiments using this approach
are limited until collaborations can be established with the labs that have access to the synthesis
of this drug.
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The role of estrogen and the estrous cycle in modulating dopamine-related
behaviors
It is well established that there are sex differences and estrous cycle effects on dopamine
release in the striatum (Becker and Cha, 1989). In this study, amphetamine was used to stimulate
dopamine release in the striatum and measured using microdialasis. During estrus, more
dopamine was released during estrus compared to diestrus. Behaviorally, this increase in
dopamine release correlated with an increase in locomotor activity. Changes in estrogen
signaling have been implicated in these effects, ovariectomizing animals can eliminate these
effects whereas replacing physiological levels of E2 reinstates them (Becker, 1990).
In the past few years, more data is emerging that dopamine neurons are sensitive to
changes in estrous cycle and estrogen levels. In vivo recordings of dopamine neurons in the VTA
show an increase in spontaneous and burst activity (Calipari et al., 2018). This might be because
of a change in dopamine receptor sensitivity or expression on dopamine neurons that effects the
feedback mechanisms that control the compensatory response of dopamine neurons to increases
in firing. Dopamine has a stronger inhibitory effect on VTA dopamine neurons in a slice
preparation during diestrus compared to estrus (Vandegrift et al., 2017). This is mimicked by
quinpirole, a selective dopamine receptor agonist, which selectively targets dopamine neurons.
Moreover, in isolated in-vitro slice preparations of the VTA, ethanol and cocaine elicit larger
responses in VTA dopamine neurons when estrogen levels are high (Vandergrift et al., 2020;
Zhang et al., 2008). Despite these observations, little has been done to quantify the physiological
response to estrous cycle in dopamine neurons the VTA.
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Estrogen signaling in the VTA: The unknowns.
There is considerable circumstantial evidence that dopamine neurons are sensitive to the
estrous cycle. However, several questions remain to be in investigated. First, it is unknown
whether the observed changes in firing patterns of VTA dopamine neurons across the estrous
cycle are due to changes in intrinsic excitability or changes in inputs to the VTA. Second, it is
unknown whether estrogen signaling is responsible for all or part of these changes. Third, it is
unknown if this phenomenon applies to all VTA dopamine neurons, or just a subpopulation of
dopamine neurons. Finally, it is unknown whether estrogen signaling in the VTA modifies the
behavioral response to stress in female mice. The following chapters will experimentally address
these questions and provide insights to the role of estrogen in the brain.
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Figure 1.1 Comparison of mouse estrous cycle and human menstrual cycle.
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Table 1.1 Ion channels identified in the VTA that are modulated by estrogen signaling.
Channel
HCN
Channels
(Ih)
KCNQ
channels

Role in VTA
Pace making, rebound,
marker of dopamine neurons

Effect of estrogen signaling
Increased HCN1 expression in
GnRH neurons

Increased conductance leads to
decreased intrinsic excitability

Increased M-current in NPY neurons
in the hypothalamus in females
treated with E2 injections

SK
channels

Switch between spontaneous and
burst firing modes, paired with
L-type calcium channels

increased E2 decreases SK3 subunit
expression in GnRH neurons in the
hypothalamus.
Changes in L-type calcium currents
in MSNs

BK
channels

Activation can increase
excitability in dopamine neurons
in the SN.
Inhibition increases magnitude
of afterhyperpolarization,
facilitates repolarization of
membrane after action potential
Component of spontaneous
pacemaker activity.

E2 treatment leads to an increase in
BK currents.
Beta 1 subunit has a binding site for
E2

NALCN

Decreases amplitude of NALCN
current
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Chapter 2: Materials and Methods
Animals
Female C57BL6/J mice were purchased from Jackson Laboratories at 7 weeks of age.
Mice were acclimated for at least one week to the animal facility before use in behavioral
experiments or surgeries. Females were monitored for estrous cycle stage to ensure they begin
cycling normally before use in any experimental procedure. All mice were housed in a 12 hour
light/dark cycle in corncob bedding with a cotton nestlet and fed regular mouse chow ad libitum.
Animals were weighed and singly housed the day before the beginning of stress. Female control
animals were housed in groups of 2-4 individuals to reduce the effect of single house stress.
Estrous Cycle Monitoring
For cell cytology determination of estrous state 10uL of phosphate buffered saline (PBS)
was gently washed over the opening of the vagina and collected using a P20 or P200 pipettor.
Samples were immediately visualized under 10x-40x magnification. Estrous cycle stage was
determined based on presence and relative quantities of cornified epithelial cells and leucocytes
(Ekambaram et al., 2017). All females were monitored for estrous cycle via vaginal cell
cytology for approximately one week to ensure they are cycling normally before any
experimental manipulation. On behavior days estrous cycle was determined via vaginal cell
cytology after all behavioral testing was completed. Vaginal cytology was performed just prior to
aCSF perfusion for slice electrophysiology. Trunk blood samples were also taken prior to
transcardial perfusion for ELISA measurements of E2 (Cayman, 582251) and progesterone (IBLAmerica, IB79183). Additionally, the uterus was removed and weighed. Whenever possible,
estrous cycle stage was confirmed with at least 2 methods of cycle determination (Figure 2.1).
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Part 1: Slice Electrophysiology
Slice Preparation
Females were swabbed for estrous cycle determination just before perfusion. Animals
were deeply anesthetized with isoflurane and transcardially perfused with ice cold, oxygenated
artificial cerebral spinal fluid (aCSF) (in mM, 128 NaCl, 10 D-glucose, 1.25 sodium phosphate
monobasic, 25 sodium bicarbonate, 2 MgCl, 3 KCl, 2 CaCl2). Approximately 500uL of blood
was collected prior to perfusion for ELISA analysis for E2 levels. The brain was extracted and
placed in ice cold oxygenated sucrose aCSF (in mM, 227 sucrose, 10 D-glucose, 1.25 sodium
phosphate monobasic, 24 sodium bicarbonate, 2 MgCl, 3 KCl, 2 CaCl 2) for one minute. Brain
tissue was blocked for the region of interest using a sharp razor blade, then sliced using a DSK
microslicer (Ted Pella) in ice cold sucrose aCSF solution under constant oxygenation. 250 um
thick slices containing the VTA were collected and allowed to recover for 1 hour at 37° C in
aCSF with constant oxygenation. The slice recovery chamber was removed from the water bath
after 1 hour and set aside at room temperature until collection for recording. A single brain slice
containing the ventral tegmental area was collected after 1 hour of recovery and placed in the
recording chamber of the electrophysiology rig. Oxygenated standard aCSF heated to 37° C with
an inline heater was constantly perfused over the slice at a rate of 3mL per minute.
Whole-Cell Recordings
A giga-ohm seal was obtained using a 1-3 MΩ pipette filled with standard internal
solution (in mM, 115 K-gluconate, 20 KCl, 1.5 MgCl, 10 Phosphocreatine-Tris, 2 ATP-Mg, 0.5
GTP-NA, 10 HEPES; adjusted to pH 7.2 and 285 mOsm). The membrane was ruptured using
pulses of fast negative suction. Membrane potential and baseline firing rate was recorded
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immediately after breaking through the membrane in I=0 current clamp configuration. Cell
health and seal quality were regularly monitored using the membrane test feature of Clampex 10.
Spontaneous firing: Membrane voltage was recorded in I=0 mode (i.e. no current
injection) for 3 minutes. The average firing rate was recorded over 3 minutes. Spikes were
detected using Clampfit (Molecular Devices). Baseline membrane voltage (Vm) and spike
afterhyperpolarization (AHP), were measured using Clampfit within the first 40 seconds of a
spontaneous firing recording. Since dopamine neurons are actively firing, the membrane voltage
was not “resting”.
Intrinsic excitability: Cells were held at -60mV at a constant current, and 2 seconds of
depolarizing current steps were added to evoke action potentials. The number of spikes for each
current step was measured using Clampfit spike detection. Two hyperpolarizing current steps
were also used to assess membrane resistance.
Hyperpolarization current: 800 ms hyperpolarizing voltage steps were used in voltage
clamp configuration in 10mV steps from -60mV holding potential. Ih was measured as the
difference in current between the initial current and the steady state current. Initial current was
measured as the current evoked immediately after the capacitive transient.
Potassium Current Recordings: After obtaining access to the cell, channel blocking
solution (1x aCSF solution, 1uM TTX, 200uM CdCl2, 1mM Kynurenic acid, 100uM picrotoxin)
was perfused onto the slice for 5 minutes. Potassium currents were recorded in voltage clamp
using 4 second long depolarizing steps from -60mV holding potential.
Membrane properties: Membrane capacitance (Cm), and membrane resistance (Rm) were
measured using the membrane test mode just after breaking into the whole cell configuration.
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These properties were also monitored throughout the recording as a proxy for cell health.
Recordings were excluded if the access resistance (Ra) changed significantly over the course of
the recording.
Part 2: Immunohistochemistry
ERβ-eGFP tissue was provided by the Milner lab. 40 um VTA sections were selected
from 5 male and 5 female animals. Slices were stored in storage medium (recipe) at -20°C until
use. Slices were washed three times in 0.1M phosphate buffer (PB), then blocked in 1% bovine
serum albumin (BSA) in PB for two hours at room temperature. Slices were then incubated
overnight at 4°C in primary antibody solution containing sheep anti-TH (1:2000, Millipore,
AB1542) and chicken anti-GFP (1:4000, Aves, GFP-1020) in 0.5% BSA in PB. Slices were
washed three times in PB for 10 minutes each wash, then incubated in secondary antibodies for 4
hours at room temperature. Slices were mounted on gelatin-coated glass slides, and cover slipped
with ProLong Gold Antifade Mountant (ThermoFisher, P10144).
For all other immunohistochemistry, deeply anesthetized animals were perfused with ice
cold phosphate buffered saline (PBS), followed by 4% paraformaldehyde (PFA). Brains were
extracted, and postfixed overnight in 4% PFA, then cryoprotected in PBS with 30% sucrose for
at least 24 hours. Brains were then sliced at 40 µm on a freezing microtome. Sections were
stored in PBS with 0.1% sodium azide until they were used for immunohistochemistry.
Slices were washed in PBS three times for 10 min each, then blocked in PBS with 2%
goat serum and 0.3% triton-X for 30 minutes. Slices were incubated in solutions containing the
primary antibodies prepared at the concentrations indicated in 2% goat serum and 0.3% triton-X
in PBS for 24-72 hours at 4C. Slices were then washed in PBS with 0.3% triton-X three times for
10 minutes each. Secondary antibodies were prepared in PBS with 2% goat serum and 0.3%
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triton-X, and slices were incubated in this solution, covered, for 1 hour at room temperature.
Slices were then washed 3 times in PBS, then mounted on charged slides using 0.5x PBS. Slices
dried overnight at room temperature, then were coverslipped with ProLong Gold Antifade
Mountant.
Part 3: Behavior
A series of behavioral stressors, stereotaxic surgeries and behavioral assays were used to
reveal changes in internal state and to gain access for modulation of VTA.
Cannula Surgeries and drug infusion
Animals were anesthetized using a cocktail of ketamine/xylazine (2/0.2 mg/kg) Animals
were head fixed in a stereotaxic apparatus (Kopf). 4mm-long bilateral cannulas were lowered
into the brain, targeting the area slightly dorsal to the VTA (-3.3 posterior to bregma, scaled to
bregma-lambda distance (Moore and Boehm, 2009)). Cannula were fixed to the scull using
MetaBond dental cement (Parkell). Animals recovered for at least 1 week before drug infusion.
Pharmacological agents were first dissolved in stock solutions of DMSO, then further diluted
into sterile 1xPBS solution for a final DMSO concentration of 0.1%. Vehicle solutions were
1xPBS with 0.1%DMSO with no drug. Drugs, their sources, and concentrations, are
summarized in table 5.1.
Acute Variable Social Stress
Female mice were exposed to one of the following stressors for 20 minutes each, with a
10-minute break between each stressor. This procedure avoids habituation or physical harm to
the mice. Control animals were transported to the lab space with the stress group and handled
daily but were placed in an adjacent room for the duration of the stressors to avoid exposure to
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stress pheromones and vocalizations from the stress group. Stressed animals were allowed to
recover for 30 minutes before returning to the animal facility.
Predator Odor Stress: The cotton tip of a sterile swab applicator was removed and 2uL
of TMT was added to the tip. Tips were placed in the home cage of the mouse for 20 minutes.
After removal of the cotton tip, the cages remained in the room for 30 minutes until the odor
dissipated. Control animals were kept in an adjacent room to avoid exposure to the odor.
Restraint and Witness to Restraint Stress: Animals were split into two groups (group A
and group B). On the first day, group A was restrained in a 50mL conical tube with air holes
drilled into the side and caps. Group A animals were placed into the home cage of group B for 20
minutes. On the next day of witness/restraint stress, group B was restrained and placed into the
home cage of group A. Control animals were transported to the lab space and kept in an adjacent
room to avoid exposure to distress calls and pheromones.
Overcrowding Stress: All mice were tail marked with unique identifiers using a colored
permanent marker for later identification and return to their established home cage. 8-10 animals
were placed in a standard sized cage for 20 minutes. Males were closely monitored for extreme
aggression and injury.
Home Cage Instability Stress: Cages were placed on a 5° incline and 800mL of roomtemperature tap water was added to the bedding. Animals were closely monitored for signs of
hypothermia. If signs of hypothermia were observed, animals were removed and placed on a
heating pad to recover. After 20 minutes, animals were placed in a new cage with fresh bedding.
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Social Interaction Test
As a measure of the rewarding nature of a social interaction the time spent interacting
with a novel social target was assessed with a social interaction test. Animals were acclimated to
the testing room for 1 hour in the dark before the beginning of testing. Testing was performed in
the dark with a red light. Animals were allowed to explore the arena for 2.5 minutes in the
presence of a small cylindrical empty cage. Velocity and location were monitored using the
Noldus Ethovision software. After 2.5 minutes, animals were removed, and a sex- and agematched novel mouse was placed in the empty cage. Animals were allowed to interact with the
novel mouse for 2.5 minutes. Velocity and location were monitored using the Noldus Ethovision
software.
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Figure 2.1 Estrous cycle determination. A) Vaginal cytology showing leucocytes, nucleated
epithelial cells, and cornified epithelial cells at each stage of the estrous cycle. Scale bars are
100μm. B) Uterine weight was significantly increased in animals during proestrus. Scale bar is 1
cm. C) Measured serum concentrations of estrogen (E2), progesterone (P4), and uterine weights
at each estrous cycle stage. D) Summary of serum concentrations of estrogen and progesterone at
estrous cycle stage. Arrows indicate mornings of each stage when serum samples were taken.
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Chapter 3: The role of hormone fluctuations across the estrous cycle on the activity of VTA
dopamine neurons.
The VTA has been well established to be a major driver of motivated behavior. In vivo
recordings from dopamine neurons have demonstrated that both aversion and reward elicit strong
bursting behavior. The region is important for drug abuse and stress behavioral responsivity. For
dopamine neurons in the VTA to be responsive to estrogen signaling across the estrous cycle,
they must express the machinery to sense and respond to estrogen, including ERs. There is
evidence from in vivo studies that the activity of VTA neurons is modified by the estrous cycle.
Because these studies use intact animals with synaptic connections still intact, it is unknown
whether this phenomenon is a result of direct modulation of dopamine neurons by sex steroid
hormones, or changes in inputs from other brain regions. While multiple whole-brain analysis of
ER expression has identified ERα and ERβ expression in the VTA, it is unknown what number
of dopamine neurons, the critical modulator of behavior, overlap with ER+ cells in the VTA.
Part 1: VTA dopamine neurons express estrogen receptors
Rationale
For sex steroid hormones to have any effect on VTA dopamine neurons, the molecular
machinery must be present in the cells. Many of these effects start with activation of ERs. This
section uses immunohistochemical methods to determine whether ERs are expressed in
dopamine neurons in the VTA. Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the
production of dopamine and is used to identify dopaminergic neurons.
Materials and Methods
ERβ: Tissue slices from Esr2-BAC transgenic mice, which express eGFP in ERβ+ cells,
was generously provided by the Milner lab. These mice were originally generated as part of the
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Gene Expression Nervous System Atlas (GENSAT) project at Rockefeller University (Gong et
al., 2003). Briefly, the mouse line was generated by inserting the coding sequence for eGFP
upstream of the coding sequence for ERβ on a bacterial artificial chromosome (BAC). These
mice were first generated on an FVB/N background, then backcrossed with wild-type C57BL/6
mice for 6 generations. These mice were then crossed with each other until a homozygotic
phenotype was achieved (Milner et al., 2010).
Two to three coronal brain slices (40μm thick) containing the VTA were selected from 5
male and 5 female animals. These slices were perfused and fixed with 4% PFA. Slices were
incubated in the primary antibody solution overnight at 4°C (Sheep anti-TH, 1:6000, Millipore,
AB1542, and chicken anti-GFP, 1:4000, Aves, GFP-1020). Slices were washed, then incubated
in the secondary antibody solution for 2 hours (1:400, goat anti-sheep AF647, ThermoFisher,
A21448; 1:400, goat anti-chicken AF488, ThermoFisher, A11039).
ERα: Tissue from wildtype C57Bl6/J female mice was blocked in 0.3% triton-x/2% goat
serum in PBS for 30 minutes, then incubated with rabbit anti-ERα (1:1000, Millipore, 06-395)
and chicken anti-TH (1:1000, Millipore, AB9702) at 4C for 48 hours. Slices were washed, then
incubated with secondary antibodies (1:600, goat anti-chicken AF488, ThermoFisher, A11039;
1:600 goat anti-rabbit AF647, ThermoFisher, A21449) for 1 hour at room temperature. Slices
were washed, mounted, and imaged using a confocal microscope.
GPER: Tissue from wildtype C578Bl/6J mice was used. Tissue was blocked in 0.3%
triton-x/1% goat serum in PBS for 30 minutes, then incubated with rabbit anti-GPER (1:200,
abcam, ab39742) and chicken anti-TH (1:1000, Millipore, AB9702) at 4C for 48 hours. Slices
were washed, then incubated with secondary antibodies (1:600, goat anti-chicken AF488,
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ThermoFisher, A11039; 1:600 goat anti-rabbit AF647, ThermoFisher, A21449) for 1 hour at
room temperature. Slices were washed, mounted, and imaged using a confocal microscope.
Results
A significant population of dopamine neurons express ERβ in adult male and female
mice (Figure 3.1A). There were no significant sex differences in the proportions of labeled
neurons. Approximately 25% of neurons that were labeled were TH+ and ERβ+. A slightly
larger proportion (approximately 30%) were TH- and ERβ+.
Nuclear expression of ERα was widespread throughout the VTA and surrounding tissue
(Figure 3.1B). Expression was not quantified, but qualitative assessment suggests that virtually
every TH+ neuron expresses nuclear ERα. GPER expression is also widespread throughout the
VTA (Figure 3.1C). Qualitative observations suggest that most TH+ neurons and many TH- cells
in the VTA express GPER. Expression of GPER appears to membrane associated, or perhaps
cytosolic, consistent with reports that GPER is associated with the membrane or endoplasmic
reticulum (Almey et al., 2016; Waters et al., 2015).
Discussion
The specificity of many antibodies raised against ERβ has been called into question, since
many of the antibodies tested in the ERβ knockout mouse line produce unexpected staining
(Snyder et al., 2010). Therefore, I used Esr2-BAC transgenic tissue, generously provided by the
Milner lab, to identify ERβ+ neurons in the VTA, and quantify their overlap with TH+ (i.e.
dopaminergic) neurons (Milner et al., 2010). This mouse line expresses eGFP in neurons that
also express ERβ by using a bacterial artificial chromosome (BAC) to drive the expression of
EGFP by inserting the sequence upstream of the coding region for Esr2. The expression patterns
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of ERβ in this mouse line are well characterized to have significant overlap with ERβ+ cells
(Milner et al., 2010).
ERβ is expressed in a large proportion of dopaminergic neurons in the VTA (Figure
3.1A). Since this mouse line is well validated to express eGFP in neurons that express ERβ, this
population of neurons are strong candidates for being sensitive to estrogen signaling.
There was also a large population of non-dopaminergic neurons that express ERβ.
Presumably, these non-dopaminergic neurons are GABAergic interneurons. Further
immunohistochemical experiments should be performed to confirm this observation.
Interestingly, there was no sex difference between male and female animals, suggesting a
possible role for neurosteroids in modulating the activity of VTA dopamine neurons in males.
ERα expression is widespread throughout the VTA, with virtually every TH+ neuron
showed nuclear staining for ERα. This is consistent with several other studies using the same
antibody (Vandegrift et al., 2020). However, there is some disagreement in the published
literature over whether ERα is expressed in the VTA. Therefore, further validation of this
antibody is necessary. A brain-wide study of the overlap between ERα and ERβ found no
expression of ERα in the VTA, with abundant ERβ expression (Mitra et al., 2003). However,
other labs have found evidence for ERα expression in dopamine neurons in the VTA (Vandegrift
et al., 2020). Because of these discrepancies, the results of these immunohistochemistry results
should be interpreted with some caution. For precise validation a ERα transgenic line to verify
the staining pattern of the antibody should be used. For this reason, only a qualitative assessment
of the expression of ERα was performed. Further studies will be done to verify the specificity of
this antibody, much like has been done for ERβ (Snyder et al., 2010).
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Nearly all VTA dopamine neurons express GPER, as well as many non-dopaminergic
neurons. In contrast to ERα, expression of this antigen appears to be membrane associated or
cytosolic. However, this antibody also needs to be validated against a GPER knockout mouse
line to proceed with more quantitative characterization in the VTA. Using in situ hybridization
techniques may be preferable to detect mRNA expression of GPER as well as ERα and ERβ.
Much less research has been done regarding the expression of GPER in the VTA. One brainwide study showed no expression of GPER in the VTA using immunohistochemistry techniques
(Hazell et al., 2009).
Since Gq-mER has not been cloned, expression of this receptor cannot be measured
through immunohistochemical methods. Expression and activity of Gq-mER must be assessed
through responsiveness to the selective agonist, STX (Qiu et al., 2006). Given the paucity of
tools for validation of anatomical presence of various ERs, the focus of this thesis is the
functional role and physiological effects of these individual ERs.
Part 2: The physiology of dopamine neurons in slice preparations of the ventral tegmental
area is modulated by the estrous cycle
Rationale
There is strong evidence for modulation of intrinsic properties of VTA dopamine
neurons, due to the many observations in changes in downstream dopamine release. However, it
is unknown whether dopamine neurons themselves are sensing changes in steroid hormones
across the estrous cycle, or if they are receiving this information through upstream inputs. In this
section, I will describe the changes in intrinsic physiology in a slice preparation of the VTA,
where only local connections are intact.
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Materials and Methods
Detailed materials and methods can be found in the slice electrophysiology section of
chapter 2. To assess whether estrous cycle influences the physiology of dopamine neurons, I
used slice electrophysiology to measure passive and dynamic properties of putative dopamine
neurons in the VTA. Recordings were made from 38 females at different stages of the estrous
cycle (8 in proestrus, 12 in estrus, 7 in metestrus, and 11 in diestrus). Neurons were presumed to
be dopaminergic based on location, size, and the presence of I h (Grace and Onn, 1989; Zhang et
al., 2010).
Results
I first measured dynamic properties of dopamine neurons using current clamp to inject
hyperpolarizing and depolarizing currents. During estrus, I found a significant increase in
intrinsic excitability, demonstrated by an increase in evoked action potentials with depolarizing
current steps (Figure 3.2A, two-way ANOVA, current injection x estrous cycle interaction, F(12,
264) =2.17,

P<0.05). I found no differences in spontaneous firing rate (Figure 3.2B, one-way

ANOVA, F(3, 92) =1.41, P = 0.244) and variability in spontaneous firing rate across the estrous
cycle (Figure 3.2C, one-way ANOVA, F(3, 88) = 0.621, P = 0.603), although the standard
deviations were significantly different for both spontaneous firing rate (Bartlett’s test, P<0.001)
and fano factor (Bartlett’s test, P<0.001).
Next, I assessed changes in ionic currents using voltage clamp recordings. There were no
differences in hyperpolarization current (Ih) (Figure 3.3A, two-way ANOVA, voltage step x
cycle interaction, F(24, 719) =0.369, P=0.99), or initial inward current (Figure 3.3B, two-way
ANOVA, voltage step x cycle interaction F(27, 459) = 0.453, P=0.99). I found a significant effect
of estrous cycle stage on peak and sustained potassium current (Figure 3.3C, two-way ANOVA
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significant voltage x cycle interaction F(33, 594) = 4.83, P<0.0001), with the highest current during
diestrus, and the lowest during estrus. Interestingly, the sustained potassium current during
metestrus was significantly increased compared to estrus (Figure 3.3D, two-way ANOVA
significant voltage x cycle interaction, F(33, 550) = 2.91, P<0.0001)
Finally, I measured several additional membrane properties of VTA dopamine neurons
across the estrous cycle. I found no differences in membrane capacitance (C m), membrane
resistance (Rm), baseline membrane voltage (Vm), and afterhyperpolarization (AHP) (Table 3.1).
Discussion
The results in this section show that estrous cycle has a significant effect on intrinsic
excitability in dopamine neurons in the VTA. During estrus, when estrogen levels are dropping
from their peak, dopamine neurons show a significant increase in intrinsic excitability compared
to other stages of the cycle. This is independent of changes in spontaneous activity. Intrinsic
excitability is the measurement of action potentials in response to a depolarizing current. This is
somewhat analogous to a response from several synaptic inputs at once and has been classically
compared to bursting activity in dopamine neurons (Grace and Bunney, 1984).
Since dopamine neurons are tonically active in slice preparations, I also measured the
spontaneous firing rate. This has been hypothesized to be responsible for background dopamine
tone. Fano factor (standard deviation/mean) is a measure of variability of firing rate within the
recording. Bartlett’s statistic is significant for spontaneous firing rate and firing rate fano factor.
This suggests that there is a subpopulation of neurons within the measured population that
changes spontaneous firing activity in response to estrous cycle stage. BK channels modulate the
spontaneous firing rate and the firing rate variability of dopamine neurons (Kimm et al., 2015).
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There was no effect of estrous cycle on Ih or the initial current evoked by a
hyperpolarizing voltage step (Figure 3.3A). This suggests that HCN channels are not modulated
by sex steroid hormones as they are in other brain regions (He et al., 2015; Ronnekleiv et al.,
2015). Ih is used to identify dopamine neurons, but there is considerable variability within
dopaminergic cells.
Initial current is a measurement of leak currents at low voltages, and inward rectifying
potassium currents at high voltages. Leak currents can change neuronal excitability by acting as
a current shunt; higher leak currents would decrease excitability since more total current is
required to reach the action potential threshold. There is no difference in this initial current, both
within the linear, leak current portion of the protocol (0mV to -40mV) as well as the inwardly
rectifying portion (-40mV to -100mV). This suggests that there is no effect of estrous cycle stage
on leak currents or inwardly rectifying currents.
Peak IK+ was significantly different across the estrous cycle, with the biggest increase
happening during diestrus, and the lowest currents during estrus (Figure 3.3 C). This was
mirrored by a change in sustained IK+, but the highest sustained currents were observed during
metestrus (Figure 3.3D). This is interesting because the currents at these timepoints are due to
different types of potassium currents; the peak measured in this protocol is analogous to A-type
potassium currents, while the sustained current is analogous to M-type currents. Both types of
potassium currents are known to be modulated by steroid hormone signaling. However, since the
M-type current is activated at the same time as A-type currents, some of the current measured at
the peak may be due to M-type currents and not A-type currents alone. Pharmacological and
physiological methods to isolate A-type from M-type currents could be used to untangle these
results.
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Membrane capacitance (Cm) is a measurement of the capacitance across the cell
membrane. Since the distance across a lipid bilayer is constant, Cm is a proxy for the surface
area of a neuron. I did not observe any differences in Cm across the estrous cycle (Table 3.1).
Membrane resistance (Rm) is the resistance across of the membrane, measured using small
(10mV) depolarizing pulses in voltage clamp. A decrease in Rm could lead to a decrease in
excitability. I did not observe any differences in Rm across the estrous cycle (Table 3.1).
Since dopaminergic neurons are spontaneously active, a “resting” membrane potential is
difficult to calculate without pharmacologically blocking voltage gated ion channels. This
blockade, in turn changes the membrane potential, leading to potentially misleading results.
Therefore, I calculated the baseline membrane voltage (Vm), as the average voltage measured
during a 20 s measurement during spontaneous firing. While this includes action potentials,
which biases the measurement toward a more depolarized potential, this value does not rely on
observer estimates and allows for the calculation of the afterhyperpolarization (AHP) after action
potentials. I did not observe any differences in Vm or AHP across the estrous cycle (Table 3.1).
Part 3: A subpopulation of dopamine neurons drives the increase in excitability during
estrus
Rationale
From the results of part 2 of this chapter, the neurons that respond to estrous cycle by
increasing their excitability during estrus seem to be a subpopulation of dopamine neurons,
rather than all dopamine neurons, similar to what is observed with expression of ERβ. This is
also reflected in the observation that the standard deviation for firing rates and firing rate
variability is larger during estrus. To better describe the population of neurons that respond to
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estrous cycle, I quantified passive and dynamic properties of high excitability neurons during
estrus (“responders”) vs low excitability neurons (“non-responders”).
Materials and Methods
Data analyzed in this section is the same data from animals in estrus and diestrus in Part
2. Neurons recorded in estrus were determined to be “high firing” by reaching a frequency higher
than 5 Hz at any point during the excitability stimulation protocol.
Results
Of the 30 putative dopamine cells (Ih more than -20pA on the last two voltage steps)
recorded from animals in estrus, 10 cells (33%) were classified as “high excitability” (Figure
3.4A and 3.4B). These high excitability neurons had higher intrinsic excitability compared to low
excitability neurons, but also all neurons recorded from animals in diestrus (Figure 3.4B, Mixedeffects analysis, current injection x group interaction, p<0.0001 F(8, 164) = 18.94. *p<0.05
between high firing and low firing, #p<0.05 between high firing and diestrus, Bonferroni
corrected). The spontaneous firing rate was significantly increased in high excitability neurons
compared to low excitability neurons and neurons from diestrus animals (Figure 3.4C, one-way
ANOVA, p<0.0001, F(2, 53) = 12.84, multiple comparisons ****p<0.0001, ***p<0.001). Ih was
significantly lower in high excitability neurons compared to low excitability neurons (Figure
3.4D, mixed-effects analysis, voltage step x group interaction, F(9, 248) = 2.855, P<0.01, multiple
comparisons did not reach significance), but not neurons from animals in diestrus (Figure 3.4D,
mixed-effects analysis, voltage step x group interaction, F(18, 426) = 0.9397, P=0.5302). The
baseline Vm was not different between high excitability, low excitability, and neurons from
diestrus animals (Figure 3.4E, one-way ANOVA, F(2, 83) = 0.4189, P=0.6592). Membrane
capacitance was lower in high excitability compared to low excitability, but not neurons recorded
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from diestrus animals. The afterhyperolarization voltage was significantly smaller in high
excitability neurons compared to neurons recorded during diestrus (Figure 3.5F, one-way
ANOVA F(2, 78) = 3.79, P=0.027). Cm was significantly higher in low excitability neurons
compared to neurons recorded in diestrus (Figure 3.4G, one-way ANOVA, F(2, 50) = 4.08
P=0.022). IK+ was not compared between these groups, since application of TTX does not allow
for intrinsic excitability to be assessed, and there were too few cells where both were recorded to
make any meaningful conclusions about IK+.
Discussion
By artificially separating the dopamine neurons from females recorded during estrus by
high and low excitability, many potential defining characteristics emerge by analyzing the other
measured parameters. By comparing these two groups to neurons that were recorded from
animals during diestrus, I can begin to understand whether there are patterns in the parameters
that are different between groups.
Interestingly, the number of high excitability neurons was similar to the number of
ERβ+/TH+ neurons quantified in figure 3.1A. Although this is a correlation, it suggests that ERβ
may be involved in modulating the excitability of dopamine neurons during estrus. To confirm
this, these recordings should be repeated using ERβ-eGFP BAC transgenic mice across the
estrous cycle, and properties from ERβ+ cells should be compared to ERβ- cells.
Low excitability neurons had nearly identical intrinsic excitability to dopamine neurons
recorded during diestrus, suggesting that the increase in variability of intrinsic excitability is
coming from an increase in excitability, not a spread between an increase and a decrease in
excitability, or a general increase in excitability in all neurons. This supports the hypothesis that
there is a population of dopamine neurons changing their physiology across the estrous cycle.
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Despite the increase in excitability, high excitability neurons had significantly lower I h
compared to low excitability neurons (Figure 3.4D). This is interesting because Ih generally acts
to increase intrinsic excitability by decreasing the time an action potential takes to repolarize
(Kase and Imoto, 2012). This suggests that there are other intrinsic parameters that are changing
to compensate and increase the intrinsic excitability. Additionally, the decreased I h suggests that
there may be a projection identity for these neurons. VTA dopamine neurons that project to the
prefrontal cortex tend to have a much smaller Ih compared to dopamine neurons that project to
the NAc (Lammel et al. 2008). Interestingly, in male mice, PFC-projecting neurons also have a
higher spontaneous firing rate compared to NAc-projecting neurons, further supporting this
hypothesis (Lammel et al., 2008). Tracing studies using viral injections into the prefrontal cortex
and NAc to retrograde label these neurons would help to confirm this hypothesis.
Several other parameters showed interesting differences between high excitability and
low excitability neurons. Spontaneous firing rate was higher for high excitability neurons,
although there were several high excitability neurons that were completely silent (Figure 3.5C).
These high excitability neurons also had significantly higher spontaneous firing rate compared to
dopamine neurons recorded from animals during diestrus, again, supporting the hypothesis that a
subpopulation of neurons changes across the estrous cycle. The baseline Vm was not significantly
different between the groups, suggesting that high excitability neurons are not simply unhealthy
neurons (Figure 3.4E). However, the afterhyperpolarization after an action potential was
significantly smaller in high excitability neurons compared to dopamine neurons from diestrus
females (Figure 3.4F). One candidate current that modulates the afterhyperpolarization that is
also modulated by steroid hormone signaling is the large conductance voltage- and calcium
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activated potassium channel (Kow and Pfaff, 2016). The reduction in AHP during estrous may
be caused by reduced activation of BK channels.
The difference in excitability may also be driven by the lower membrane capacitance in
the high excitability group (Figure 3.4G). A lower capacitance indicates a smaller surface area,
which would cause a current injection to have a larger effect on membrane voltage. If the neuron
size is assumed to be stable, then low capacitance neurons at other stages of the cycle would
have a compensatory mechanism to counteract the effects of the low capacitance.
Part 4: Discussion
Data from this chapter shows that ERs are present in the VTA, and are expressed on
dopamine neurons, suggesting that the VTA is sensitive to the effects of the estrous cycle. I show
this through whole cell patch clamp recordings across the estrous cycle, when hormone levels are
dramatically fluctuating in female mice. Notably, the intrinsic excitability is markedly increased
during estrus when estrogen levels are rapidly falling. This is driven by a dramatic increase in a
subpopulation of neurons, which have unique characteristics compared to neurons that do not
change excitability during estrus.
This is the first time that physiology across estrous cycle in intrinsic properties of
dopamine neurons have been described, despite considerable evidence for sex differences in the
dopamine system. The implications of these findings are far-reaching since dopamine neuron
activity in the VTA is implicated in many behaviors, including salience, reward, and stress
responsivity. Interestingly, many of these behaviors have also been linked to sex differences and
changes across the estrous cycle. Changes in the activity of dopamine neurons across the estrous
cycle may be one mechanism through which these behaviors are modulated.
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Future directions to extend these results should include studies that investigate the
behavior of different populations of neurons in the VTA. The VTA is an extremely diverse
structure, and more evidence is emerging that discrete populations of dopamine neurons have
different roles. In this chapter, I showed that a physiologically distinct population of neurons
responds to the estrous cycle. However, the phenotypic and projection identity of these neurons
remains unclear.
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Figure 3.1: VTA dopamine neurons express estrogen receptors. A) TH (green) and ERβ-eGFP
(magenta) double immunohistochemistry. Scale bars are 100 μm. No sex differences were
observed in expression patterns (Two-way ANOVA, cell type x sex interaction, F(2, 16) = 0.0179,
P=0.982). B) TH (green) and ERα (magenta) double immunohistochemistry showing widespread
nuclear labeling. Scale bars are 100 μm and 10μm (inset). C) TH (green) and GPER (magenta)
double immunohistochemistry showing widespread cytosolic labeling. Scale bars are 100 μm
and 10μm (inset).
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Figure 3.2 Physiology of VTA dopamine neurons changes across the estrous cycle. A) Intrinsic
excitability is increased during estrus compared to proestrus and metestrus. (Two-way ANOVA,
current injection x estrous cycle stage interaction, p<0.05, F (12, 264) = 2.168.) Multiple
comparisons with Bonferoni’s correction between estrus and proestrus (*, p<0.05), and estrus
and metestrus (♯, p<0.05) B) Spontaneous firing rate does not change across the estrous cycle
(One-way ANOVA, F(3, 92) = 1.41, P=0.244) C) Fano factor, a measure of variability in firing
rate, does not change across estrous cycle (One-way ANOVA, F(3, 88) = 0.621, P=0.603).
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Figure 3.3: Ih and potassium current across the estrous cycle. A) Hyperpolarization current (Ih)
across the estrous cycle does not change. (Two-way ANOVA, voltage step x cycle interaction
F(24, 719) = 0.368 P=0.99,) B) The initial current evoked by a hyperpolarizing voltage injection
does not change across the estrous cycle. C) Peak potassium current across the estrous cycle is
increased in diestrus (Two-way ANOVA, voltage step x cycle interaction F(33, 594) = 4.835,
P<0.0001; multiple comparisons * p<0.05 **p<0.01 between estrus and diestrus; +p<0.05
between proestrus and diestrus.) D) Sustained potassium current is increased during metestrus
(Two-way ANOVA significant voltage x cycle interaction, F(33, 550) = 2.913, P<0.0001; multiple
comparisons #p<0.01 between estrus and metestrus).
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Table 3.1 Intrinsic properties of dopamine neurons across the estrous cycle.
Proestrus

Estrus

Metestrus

Diestrus

Vm (mV)

-39.0 +/-3.6 (16)

-40.2 +/-6.1 (52)

-37.4 +/-6.2 (10)

-39.3 +/-6.1 (56)

Cm (pF)

46.3 +/- 14.9 (14)

48.9 +/-16.3 (39)

49.7 +/-16.4 (19)

49.4 +/-16.4 (39)

Rm (MΩ)

226.1 +/- 98.1 (14)

274.3 +/- 139.0

119.3 +/- 77.5 (18)

226.3 +/- 115.8 (39)

-10.30 +/- 3.3 (11)

-11.01 +/- 4.4 (51)

(39)
Spike AHP (mV)

-11.23 +/- 3.3 (15)

-10.15 +/- 3.7 (35)
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Figure 3.4: A population of VTA dopamine neurons respond to estrus. A) 33% of neurons
recorded in estrus were determined to be “high firing”. B) High excitability neurons compared to
low firing neurons, and all neurons during diestrus. (Mixed-effects analysis, significant
interaction between current injection and group, F(8, 164) = 18.94, P<0.0001; multiple
comparisons, *p<0.05 between high excitability neurons and low excitability neurons, #p<0.05
between high excitability and diestrus) C) Spontaneous firing in neurons with high excitability is
higher than neurons with low excitability, and neurons recorded during diestrus (One-way
ANOVA, F(2, 53) = 12.84, P<0.0001; multiple comparisons ****p<0.0001, ***p<0.001). Note
that there are several silent high excitability neurons. D) Ih of high excitability neurons is
significantly lower when compared to low excitability neurons (Mixed-effects analysis, voltage
step x group interaction, F(9, 248) = 2.855, P<0.01; multiple comparisons did not reach
significance) but does not reach significance when compared to diestrus neurons (Mixed-effects
analysis, voltage step x group interaction F(18, 426) = 0.9397, P=0.530) E) There is no difference in
baseline membrane voltage between groups (One-way ANOVA, F(2, 83) = 0.419, P =0.660). F)
The afterhyperpolarization antipeak is significantly lower in high excitability neurons than in
diestrus neurons, but no different from low excitability neurons in estrus (One-way ANOVA F(2,
78)

= 3.80 p=0.027). G) The membrane capacitance of high excitability neurons is significantly

lower than low excitability neurons. (One-way ANOVA, F(2, 50) = 4.08, P=0.023; multiple
comparisons, *p<0.05).
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Chapter 4: The role of estrogen signaling in the ventral tegmental area
Fluctuations in estrogen levels are a critical component of the female hormonal cycle.
These fluctuations are also responsible for changes in neuronal physiology across the estrous
cycle in several brain regions. In this chapter, I describe my findings that show that estrogen
signaling is involved in the changes observed in VTA dopamine neuron physiology across the
estrous cycle through pharmacological manipulations of estrogen signaling in a slice preparation
of the VTA.
Part 1: Estrogen incubation changes dopamine neuron physiology in an estrous cycle
dependent manner.
Rationale
Estrogen signaling is likely partially responsible for the changes in intrinsic excitability
that I observed across the estrous cycle (chapter 3). This is because 1) estrogen levels are rapidly
decreasing during estrus, when I observe a significant increase in excitability and 2) estrogen is
well known to induce both slow, protein synthesis dependent changes in excitability, and rapid
changes in excitability in other regions of the brain.
Materials and methods
For this set of experiments, I used 34 female mice at all stages of the estrous cycle (12
proestrus, 8 estrus, 7 metestrus, 7 diestrus) and 5 male mice. VTA slices were hemisected just
after slicing, and one half of each slice recovered for at least one hour in either 1uM E2, or
standard aCSF containing 0.1% DMSO as a vehicle control (Figure 4.1).
Results
During proestrus, E2 treatment caused a significant decrease in intrinsic excitability
(Figure 4.2A, two-way ANOVA, current step x treatment interaction, F(7, 294) = 3.08, P=0.004).
52

Estrogen incubation did not change the spontaneous firing rate (Figure 4.2B, unpaired t-test,
P=0.21), but did decrease the spontaneous firing rate variability (Figure 4.2C, unpaired t-test,
P=0.035). Estrogen treatment did not affect Ih (Figure 4.2D, two-way ANOVA, voltage step x
treatment interaction F(9, 531) = 0.796, P=0.620), peak potassium current (Figure 4.2E, two-way
ANOVA, voltage step x treatment interaction, F(11, 297) = 0.501, P=0.901), or sustained potassium
current (Figure 4.2F, two-way ANOVA, voltage step x treatment interaction, F(11, 341) = 1.25,
P=0.255). Other membrane properties, including Vm, Cm¸ AHP, and Rm were unaffected by
estrogen incubation (Table 4.1).
During estrus, E2 significantly decreased intrinsic excitability in dopamine neurons
(Figure 4.3A, two-way ANOVA, current step x treatment interaction, F(7, 168) = 3.60, P=0.0012).
Spontaneous firing rate was unaffected by estrogen treatment (Figure 4.3B, unpaired t test,
P=0.317), as was spontaneous firing rate variability (Figure 4.3C, unpaired t test, P=0.268).
Estrogen treatment did not affect Ih (Figure 4.3D, two-way ANOVA, voltage step x treatment
interaction F(9, 261) = 0.04460, P>0.99). Peak potassium current (Figure 4.3E, two-way ANOVA,
voltage step x treatment interaction F(11, 132) = 0.972, P=0.475) and sustained potassium current
(Figure 4.3F, two-way ANOVA, voltage step x treatment interaction, F(11, 154) = 0.265 P=0.9911)
were also unaffected. Other membrane properties, including Vm, Cm¸ AHP, and Rm were
unaffected by estrogen incubation (Table 4.2).
During metestrus, estrogen treatment has the opposite effect on intrinsic excitability,
where 1uM of E2 increases excitability (Figure 4.4A, two-way ANOVA current step x treatment
interaction, F(7, 91) = 2.64, P=0.0157). There was also no effect on spontaneous firing rate (Figure
4.4B, unpaired t test, P=0.955), or firing rate variability (Figure 4.4C, unpaired t test, P=0.682).
Ih was unaffected by estrogen treatment (Figure 4.4D, two-way ANOVA, voltage step x
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treatment interaction, F(9, 189) = 0.167, P=0.997). Estrogen treatment significantly increased peak
potassium current (Figure 4.4E, two-way ANOVA, voltage step x treatment interaction, F(11, 143)=
2.77, P=0.0028) and sustained potassium current (Figure 4.4 F, two-way ANOVA, voltage step x
treatment interaction, F(11, 121) = 4.25, P<0.0001). Other membrane properties, including Vm, Cm¸
AHP, and Rm were unaffected by estrogen incubation (Table 4.3).
During diestrus, estrogen treatment did not affect intrinsic excitability (Figure 4.5A,
Two-way ANOVA, current step x treatment interaction F(7, 189) = 0.363, P=0.923). Estrogen
treatment did not affect spontaneous firing rate (Figure 4.5B, unpaired t test, P=0.143), or firing
rate variability (Figure 4.5C, unpaired t test, P=0.370). Ih was also unaffected by estrogen
treatment (Figure 4.5D, mixed-effects analysis, voltage step x treatment, F(9, 376) = 0.0582,
P>0.9999). Peak potassium current (Figure 4.5E, two-way ANOVA, treatment x voltage step
interaction, F(11, 99) = 0.110, P=0.999) and sustained potassium current were also unaffected
(Figure 4.5F, two-way ANOVA, treatment x voltage step interaction, F(11, 99) = 0.137, P=0.999).
Other membrane properties, including Vm, Cm¸ AHP, and Rm were unaffected by estrogen
incubation (Table 4.4).
Discussion
This set of experiments shows that estrogen signaling influences the physiology of
dopamine neurons in a slice preparation in female animals through changes in intrinsic
excitability. Since potassium currents are heavily involved in modulating intrinsic excitability, I
was surprised to find no differences in IK+ across the different stages. However, I only observed
an increase in IK+ during metestrus. Surprisingly, an increase in IK+ was accompanied by an
increase in intrinsic excitability during this stage, suggesting that different mechanisms are
involved in modulating the response to estrogen. Since progesterone levels are also high during
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metestrus, there may also be an interaction between estrogen signaling and progesterone
signaling that is causing these interesting results. Further experiments should utilize a cocktail of
estrogen and progesterone to determine if this increase in I K+ can be induced in other stages of
the estrous cycle.
Further experiments in this area should address more specifics about the time and dose
response of estrogen signaling in the VTA. Time response will indicate whether transcriptional
changes are happening (slow) or more rapid (i.e., membrane associated) changes are occurring.
Additionally, different doses of estrogen may have different effects on physiology, as happens in
the hypothalamus.
Part 2: Inhibition of estrogen signaling in slice preparations
Rationale
Since incubation with estrogen decreased intrinsic excitability in estrus and proestrus, I
hypothesized that inhibiting estrogen signaling would reverse this phenotype. To determine the
specific receptor involved, I used the ERβ antagonist, PHTPP, to test whether specific inhibition
of ERβ could change the excitability of VTA dopamine neurons. Since proestrus naturally has
high estrogen, and the excitability is already very low, I used animals that were in proestrus for
this experiment.
Materials and Methods
Seven neurons from five animals were recorded. For this experiment, I used animals in
Proestrus (based on uterine weight). Dopaminergic cells were identified by the presence of Ih
prior to any drug being washed on. Once a dopaminergic cell was identified, baseline intrinsic
excitability was recorded. 1 µM PHTPP was washed on and the excitability was immediately
recorded. Excitability was recorded every 5 minutes in the presence of PHTPP. After 30 minutes,
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PHTPP was washed off, and excitability was recorded after 10 minutes in regular aCSF solution.
In order to directly compare the effects of PHTPP at different time points in different cells, the
number of action potentials evoked with 125pA of injected current at each time point were
normalized to baseline.
Results
Similar to what I observed in chapter 3, part 3, a subpopulation of neurons responded to
PHTPP .Two out of seven neurons showed a decrease in excitability from the baseline (Figure
4.6A and B, Mixed-effects analysis, F(8, 29) = 3.87, P=0.0033). The proportion of responder and
non-responder neurons also reflects the distribution of ERs observed with
immunohistochemistry in chapter 3, part 1.
Discussion
The results of this experiment show a surprising result that blocking ERβ reduces
excitability in a subpopulation of neurons. This is surprising because estrogen incubation
decreases excitability during proestrus (Figure 4.2A). However, there are several explanations.
First, since estrogen incubation is non-specific, the excitability reduction effect of estrogen
incubation may be due to the actions of a different receptor. Second, since the slices in part 1
were incubated in estrogen rather than bath applied, the short-term activities of estrogen my
work to increase excitability, while long-term actions may reduce excitability. This experiment
highlights the possible rapid vs. genomic effects of estrogen’s action.
From chapter 3 results, a moderate population of neurons responds to the estrous cycle,
which I hypothesize are ERβ+. For this experiment, I used wildtype animals to record VTA
dopamine neurons without knowing their ER phenotype. Because I recorded one cell per slice,
the chances that the neuron that I recorded from was ERβ+ was relatively low. Post-hoc
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confirmation of ERβ phenotype was not possible since antibodies for ERβ are not specific. It is
possible that the decrease in excitability is due to an increase in inhibitory input onto the
dopamine neurons, especially since a large portion of ERβ+ neurons are not dopaminergic.
Targeting ERβ+ neurons using VTA slices from ERβ-eGFP mice would clarify whether the
reduction in excitability in a subpopulation of dopamine neurons after being treated with PHTPP
are due to direct action on the neurons being recorded.
Part 3: Discussion
These results demonstrate that estrogen signaling plays a role in dopamine physiology in
the VTA. Incubation with E2 induced changes in excitability, spontaneous firing variability, and
potassium currents. Moreover, these results depend on the estrous cycle stage, suggesting that
there is an interaction between estrogen signaling and factors that change across the estrous
cycle, most likely progesterone.
The effects of estrogen signaling on dopamine neurons in the VTA can be excitatory or
inhibitory. During proestrus and estrus, estrogen incubation leads to a decrease in intrinsic
excitability, whereas during metestrus, estrogen incubation increases intrinsic excitability.
Additionally, the mechanism underlying this change in excitability is unclear, with no changes in
IK+ observed when excitability was reduced, and a counterintuitive increase in I K+ during
metestrus, when estrogen incubation increased excitability. This increase in I K+ may be a direct
result of estrogen signaling or may be a compensatory response to an increase in excitability.
Since I used a supraphysiological concentration of E2 in these experiments, some more subtle
effects of estrogen signaling at physiological concentrations may have been lost. An estrogen
dose-response experiment would be valuable to untangle the roles of the different receptors in
the VTA.
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Progesterone signaling is also very likely involved in modulating dopamine neuron
excitability in the VTA. During metestrus, when the effects of estrogen on neuronal excitability
reverse, the levels of progesterone are also high (Figure 2.1C). This is also supported by
behavioral studies that use estrogen to prime the VTA to be sensitive to the effects of
progesterone (Frye et al., 2014). Pharmacological experiments combining estrogen and
progesterone signaling could help untangle the relationship between the two steroid hormones.
The results of the ERβ antagonist experiment in part 2 also support the idea of multiple
mechanisms of estrogen signaling in the VTA. I chose to focus on ERβ due to my observations
from chapter 3, since the proportion of ERβ+ neurons (Figure 3.1A) is similar to the proportion
of high excitability neurons during estrus (Figure 3.5A). The decrease in excitability induced by
PHTPP was surprising, given that estrogen has the same effect in proestrus and estrus. However,
the effects of PHTPP may be reversing the mechanism that increases the excitability of
dopamine neurons during metestrus (Figure 4.4A), while the decrease in excitability during
proestrus and estrus may be due to the actions of ERα, GPER, or Gq-mER. Since the effects of
estrogen in the VTA seem to be working through multiple ERs, more experiments using agonists
and antagonists specific to the different ERs will be useful in fully understanding the effects of
estrogen from part 1.
Another remaining question from this chapter involves the role of estrogen signaling in
males. In chapter 2, I found similar expression patterns of ERβ in the VTA of male and female
mice. Although male mice do not experience estrogen fluctuations to the degree that females do,
aromatase, the enzyme that converts testosterone to estrogen, is produced in the brain (GarciaSegura, 2008). Further experiments will need to be performed to uncover the role of estrogen

58

signaling in males. This would also help to uncover the role of neuroestrogens in modulating the
physiology of dopamine neurons in the VTA.
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Figure 4.1 Experimental design of estrogen incubation experiment. Individual slices were
hemisected, and each half recovered for at least 1 hour in aCSF containing either 1uM E2, or a
DMSO control (Standard aCSF).
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Figure 4.2 The effects of estrogen incubation on dopamine neurons during proestrus. A)
Incubation in 1uM estradiol reduces excitability (Two-way ANOVA, current step x treatment
interaction, F(7, 294) = 3.081, P=0.0038. Multiple comparisons were not significant). B) Estradiol
incubation does not change spontaneous firing rate (Unpaired t-test, P=0.21) C) Estradiol
incubation significantly decreases firing rate variability (Unpaired t-test, P=0.0353). D) Estradiol
incubation does not change Ih (Two-way ANOVA, voltage step x treatment interaction F(9, 531) =
0.7959, P=0.6202). E) Estradiol incubation does not change peak potassium current (Two-way
ANOVA, voltage step x treatment interaction, F(11, 297) = 0.5013,P=0.9019) F) Estradiol
incubation does not change sustained potassium current (Two-way ANOVA, voltage step x
treatment interaction, F(11, 341) = 1.246, P=0.2554).
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Table 4.1 Effects of estrogen incubation on intrinsic properties during proestrus.
Proestrus

Control

Estrogen

Vm (mV)

-42.8 +/- 7.3 (29)

-41.9 +/- 5.3 (29)

Cm (pF)

47.5 +/- 12.4 (27)

52.61 +/- 16.8 (28)

Rm (MΩ)

241.6 +/- 134.7 (27)

258.1 +/- 146.3 (28)

Spike AHP (mV)

-10.3 +/- 4.0 (18)

-11.9 +/- 4.5 (24)

62

Figure 4.3 The effects of estrogen incubation on dopamine neurons during estrus. A) Estrogen
incubation reduces excitability (Two-way ANOVA, current step x treatment interaction, F(7, 168)
= 3.602, P=0.0012). B) There is no effect of estrogen incubation on spontaneous firing rate
(Unpaired t test, P=0.3167). C)There is no effect of estrogen incubation on firing rate variability
(Unpaired t test, P=0.2676). D) There was no effect of estrogen incubation on Ih (Two-way
ANOVA, voltage step x treatment interaction F(9, 261) = 0.04460, P>0.9999). E) There was no
effect of estrogen incubation on peak potassium current (Two-way ANOVA, voltage step x
treatment interaction F(11, 132) = 0.9719, P=0.4751). F) There was no effect of estrogen incubation
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on sustained potassium current (Two-way ANOVA, voltage step x treatment interaction, F(11, 154)
= 0.2651, P=0.9911).
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Table 4.2 Effects of estrogen incubation on intrinsic properties during estrus.
Estrus

Control

Estrogen

Vm (mV)

-41.6 +/- 5.6 (22)

-38.13 +/- 5.3 (13)

Cm (pF)

51.8 +/- 13.4 (21)

54.3 +/- 10.6 (13)

Rm (MΩ)

298.0 +/- 132.1 (21)

271.5 +/- 174.7 (13)

Spike AHP (mV)

-9.7 +/- 3.8 (20)

-8.2 +/- 4.5 (12)
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Figure 4.4 The effects of estrogen incubation on dopamine neurons during metestrus. A)
Incubation with estradiol increases excitability during metestrus (Two-way ANOVA current step
x treatment interaction, F(7, 91) = 2.639, P=0.0157). B) There is no effect of estradiol incubation
on spontaneous firing rate (Unpaired t test, P=0.9549). C) There is no effect of estradiol
incubation on firing rate variability (Unpaired t test, P=0.6818). D) There is no effect of estradiol
signaling on Ih (Two-way ANOVA, voltage step x treatment interaction, F(9, 189) = 0.1667,
P=0.9970) E) Incubation with estradiol increases peak potassium current (Two-way ANOVA,
voltage step x treatment interaction, F(11, 143) = 2.765, P=0.0028) F) Incubation with estradiol
increases sustained potassium current (Two-way ANOVA, voltage step x treatment interaction,
F(11, 121) = 4.248, P<0.0001).
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Table 4.3 Effects of estrogen incubation on intrinsic properties during metestrus.
Metestrus

Control

Estrogen

Vm (mV)

-39.7 +/- 4.6 (17)

-39.7 +/- 6.3 (12)

Cm (pF)

58.26 +/- 18.8 (15)

58.2 +/- 22.35 (11)

Rm (MΩ)

283.8 +/- 205.1 (15)

220.0 +/- 102.9 (11)

Spike AHP (mV)

-10.3 +/- 5.2 (16)

-8.9 +/- 4.1 (8)

67

Figure 4.5 The effects of estrogen incubation on dopamine neurons during diestrus. A) Estradiol
incubation does not affect intrinsic excitability (Two-way ANOVA, current step x treatment
interaction F(7, 189) = 0.3628, P=0.9228), B) Estradiol incubation does not change spontaneous
firing rate (Unpaired t test, P=0.1430). C) Estradiol incubation does not change firing rate
variability (Unpaired t test, P=.3696), D) Estradiol incubation does not change Ih (Mixed-effects
analysis, voltage step x treatment, F(9, 376) = 0.05828, P>0.9999). E) Estradiol incubation does not
change peak potassium current (Two-way ANOVA, treatment x voltage step interaction, F(11, 99)
= 0.1101, P=0.9998). F) Estradiol incubation does not change sustained potassium current (Twoway ANOVA, treatment x voltage step interaction, F(11, 99) = 0.1377, P=0.9995).
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Table 4.4 Effects of estrogen incubation on intrinsic properties during diestrus.
Diestrus

Control

Estrogen

Vm (mV)

-41.3 +/- 5.3 (19)

-38.92 +/- 5.9 (23)

Cm (pF)

53.2 +/- 18.6 (16)

53.1 +/- 19.5 (19)

Rm (MΩ)

249.2 +/- 153.6 (16)

278.4 +/- 188.2 (19)

Spike AHP (mV)

-10.27 +/- 5.6 (15)

-9.9 +/- 3.3 (17)
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Figure 4.6 The effects of ERβ incubation during proestrus. A) Example traces showing a
responder (black) and non-responder (red). B) Two out of eight neurons from five different
animals show a decrease in excitability in response to 1uM PHTPP (Mixed-effects analysis, F(8,
29)

= 3.874, P=0.0033).
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Chapter 5: Behavioral response to estrogen signaling in the VTA
The VTA is an important node in the behavioral response to stress. In males, changes in
the excitability and potassium current drive behavioral resiliency to stress. I have shown a role of
estrogen signaling in modulating the excitability of dopamine neurons in females. However, it is
unknown whether there is a behavioral consequence to changes in excitability in these neurons.
This chapter will describe results showing the role of estrogen signaling in the VTA in
modulating behavior, especially the behavioral response to stress.
Part 1: Changes in the behavioral response to stress across the estrous cycle
Rationale
To test whether estrous cycle interacts with stress to affect social interaction in female
mice, I used a combination of psychosocial stressors and exposed a group of naturally cycling
females to a one-day stress paradigm and measured social interaction the next day. This
paradigm allows for any long-term changes that stress may induce to be revealed behaviorally.
Materials and methods
To validate that acute variable social stress (AVSS) increases serum corticosterone levels,
a group of 16 female mice were exposed to AVSS. As the group progressed through the stress
paradigm, 4 females were sacrificed immediately after each stressor to collect serum for
corticosterone level measurements via ELISA. Serum was also collected from 4 unstressed
females prior to AVSS and 4 unstressed females after AVSS to account for differences in
corticosterone levels at different times during the day.
To measure changes in social interaction after AVSS, a group of 64 female mice were
exposed to either AVSS (n=32) or handled as controls (n=32), then vaginally swabbed to
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monitor their estrous cycle. 24 hours later, social interaction was measured in all animals, then
mice were vaginally swabbed to monitor estrous cycle.
Results
There was no statistical difference between the corticosterone levels of control females
sacrificed before and after AVSS, so their corticosterone levels were pooled for this analysis.
AVSS significantly increases serum corticosterone levels (Figure 5.1B, (1 way ANOVA, F(6, 27)
= 16.10, P<0.0001).
Females that were exposed to AVSS showed a significant reduction in social interaction
compared to unstressed controls (Figure 5.1C, unpaired t test, **p<0.01). When analyzed by
estrous cycle on the day of AVSS, animals that were in estrus on the day of stress showed a
significant decrease in social interaction compared to unstressed control females who were in
estrus on the same day (Two-way ANOVA, stress x estrous cycle stage interaction, F(3, 48) =
3.019, P=0.387; multiple comparisons between stress and control for each cycle stage,
***P>0.001). When the data from the same group of animals was analyzed by estrous cycle on
the day of social interaction, however, there was no significant difference in social interaction
time (Two-way ANOVA, cycle x stress interaction, F(3, 45) = 1.618 P=0.1984).
Discussion
This is the first time AVSS has been used to induce behavioral changes in female mice. I
have validated that AVSS increases serum corticosterone levels in female mice (Figure 5.1B).
This paradigm is powerful because it can be used effectively in both sexes and uses stressors that
include a psychological component: a predator odor suggests that threat is nearby, but does not
physically harm the mouse; witnessing a restrained conspecific struggle induces empathy-like
behaviors, such as digging around the conical tube, chewing on the tube, and increased
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locomotion while the tube is in the cage; overcrowding increases potential competition; and
home cage instability disrupts an environment that was previously dry and comfortable.
Behaviorally, AVSS induces a reduction in social interaction when a large enough group
is analyzed together (Figure 5.1C). This effect is driven by the animals that are in estrus on the
day of AVSS (Figure 5.1D). Interestingly, there is no effect of estrous cycle if the same data is
analyzed by the estrous cycle stage on the day of social interaction (Figure 5.1E). This suggests
that the hormonal status of the animal when it is experiencing stress has a stronger effect on the
behavioral outcome than the hormonal status at the time of the behavioral challenge.
Several studies find either no changes or subtle changes in social interaction behavior
across the estrous cycle in unstressed female rodents (Trainor et al., 2013; Scholl et al., 2019;
Chari et al., 2020). However, there is evidence that stress interacts with estrous cycle to unmask
estrous cycle behavioral differences, best studied in the memory literature (Conrad et al., 2004;
Hokenson et al., 2021; Shansky et al., 2006). This phenomenon has been observed in humans
(Kajantie and Phillips, 2006).
This experiment does not directly implicate the ventral tegmental area in driving these
effects, although social interaction is rewarding to mice, and psychosocial stress has been
strongly linked to dysfunction in the dopamine system in humans and mice (Bloomfield et al.,
2019; Russo and Nestler, 2013). This experiment also considers the role of estrous cycle stage,
where there are many different hormones changing. The remaining experiments in this chapter
will explore the behavioral effects of pharmacological inhibition of estrogen signaling in the
ventral tegmental area.
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Part 2: Pharmacological manipulation of VTA dopamine neurons during stress acquisition
Rationale
To test whether estrogen signaling in the VTA is responsible for the reduction in social
interaction when a female mouse is exposed to stress during estrus, I infused ER agonists and
antagonists over several separate experiments directly into the VTA just before stress acquisition
to test the role of declining estrogen signaling in the behavioral response to stress. Additionally,
in a separate set of experiments I infused these antagonists just prior to the social interaction test.
During these experiments all behaviors are recorded and undergo to full behavioral
analysis. I measured several parameters: the time spent in the interaction zone to measure social
drive, the velocity (cm/s) of the animal as it moved around the arena to assess whether drug
infusion has any effect on locomotion, and the amount of time spent in the outer perimeter of the
arena to assess anxiety (Simon et al., 1994). These parameters have been shown previously to be
dependent on dopamine activity (Simon et al., 1994; Koob and Nestler, 1997)
Materials and methods
Table 5.1 describes the drugs and concentrations used in these experiments. In all
experiments, animals were cannulated and allowed to recover for at least 1 week. For AVSS
experiments, drugs were infused on the day of stress and social interaction was measured 24
hours later. To assess the acute effects of each drug, drugs were infused and social interaction
was measured on the same day.
Results
ICI infusion: To test whether estrogen signaling is involved in the effect of reducing
social interaction after stress, the ER antagonist, ICI 182, 780 (ICI) was infused into the VTA
prior to AVSS (Figure 5.2A). There were no differences between groups in time spent in the
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interaction zone in the absence (Figure 5.2C, two-way ANOVA, stress x drug interaction, F(1, 30)
= 1.09, P=0.305). However, in the presence of a social target, the ICI/AVSS group showed a
significant decrease in time spent in the interaction zone (Figure 5.2G, two-way ANOVA, stress
x drug interaction, F(1, 30) = 6.92, P=0.0133). There was no difference in velocity between groups
in the absence of a social target (Figure 5.2D, two-way ANOVA, stress x drug interaction F(1, 30)
= 0.764, P=0.389). There was also no difference in velocity between the groups in the presence
of a social target (Figure 5.2H, two-way ANOVA, stress x drug interaction, F(1, 30) = 0.0451,
P=0.833). There was no difference between groups in time spent in the outer zone in the absence
of a social target (Figure 5.2E, two-way ANOVA, stress x drug interaction, F(1, 30) = 1.73,
P=0.198). However, there was a significant interaction between stress and drug infusion on the
time spent in the outer zone in the presence of a social target (Figure 5.2I, two-way ANOVA,
stress x drug interaction, F(1, 30) = 5.569, P=0.0250).
I then tested the effect of infusion of ICI just prior to social interaction. There was a no
change in time spent in the social interaction zone in the absence of a social target (Figure 5.3C,
unpaired t test, P=0.1923). Animals that received an infusion of ICI spent less time in the
interaction zone compared to animals that received a vehicle infusion (Figure 5.3G, unpaired t
test, P=0.019). There was also a significant increase in velocity in the absence (Figure 5.3D,
unpaired t test, P=0.029) and presence of a social target (Figure 5.3H, unpaired t test, P=0.0004)
There was no change in the time spent in the outer zone in the absence (Figure 5.3E, unpaired t
test, P=0.476) and the presence of a social target (Figure 5.3I, unpaired t test, P=0.749).
PHTPP infusion: To test whether ERβ is involved in the effect of reducing social
interaction after stress, the specific ERβ antagonist, PHTPP was infused into the VTA prior to
AVSS. There were no differences between groups in time spent in the interaction zone in the
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absence (Figure 5.3C, two-way ANOVA, stress x drug interaction, F(1, 16) = 0.00312, P=0.956) or
presence of a social target (Figure 5.3G, two-way ANOVA, stress x drug interaction, F(1, 16) =
0.489, P=0.495). There was a significant increase in velocity between non-stressed vehicle and
PHTPP infused females (Figure 5.3D, two-way ANOVA, stress x drug interaction, F(1, 16) =
5.354, P=0.0343). This did not reach significance in the presence of a social target (Figure 5.3H,
two-way ANOVA, stress x drug interaction, F(1, 16) = 1.63, P=0.220). There was no difference
between groups in time spent in the outer zone in the absence (Figure 5.3E, two-way ANOVA,
stress x drug interaction, F(1, 16) = 0.116, P=0.738) or presence of a social target (Figure 5.3I,
two-way ANOVA, stress x drug interaction, F(1, 16) = 0.316, P=0.582).
I then tested the effect of infusion of PHTPP just prior to social interaction. There was a
significant increase in time spent in the social interaction zone in the absence of a social target
(Figure 5.4C, unpaired t test, P=0.0115). There was a trend towards increasing time spent in the
interaction zone in the presence of a social target (Figure 5.4G, unpaired t test, P=0.0836). There
was also a significant increase in velocity in the absence (Figure 5.4D, unpaired t test, P=0.0157)
and presence of a social target (Figure 5.4H, unpaired t test, P=0.0157). There was also a
significant reduction in the time spent in the outer zone in the absence (Figure 5.4E, unpaired t
test, P=0.0488) but not the presence of a social target (Figure 5.4I, Unpaired t test, P=0.296).
G1 infusion: Since ICI is an agonist of GPER, I used the GPER agonist, G1 to test
whether the activation of GPER receptors is responsible for the reduction of social interaction
seen with ICI infusions. G1 infusion had no effect on time spent in the social interaction zone in
the absence (Figure 5.5C, two-way ANOVA, stress x drug interaction, F(1, 15) = 2.55, P=0.131) or
presence of a social target (Figure 5.5G, two-way ANOVA, stress x drug interaction, F(1, 15) =
0.921, P=0.352). There were no effects of G1 infusion on velocity in the absence (Figure 5.5D,
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two-way ANOVA, stress x drug interaction, F(1, 15) = 0.466, P=0.506) or presence of a social
target (Figure 5.5H, two-way ANOVA, stress x drug interaction, F(1, 15) = 0.00050, P=0.983).
There were no effects of G1 infusion on time spent in the outer zone in the absence (Figure 5.5E,
two-way ANOVA, stress x drug interaction, F(1, 15) = 1.93, P=0.185) or presence of a social
target (Figure 5.5I, two-way ANOVA, stress x drug interaction, F(1, 15) = 0.438, P=0.518).
I next tested whether G1 effects social interaction when infused just prior to the test.
There were no effects of G1 infusion on time spent in the interaction zone in the absence (Figure
5.6C, unpaired t test, P=0.612) and presence of a social target (Figure 5.6G, unpaired t test,
0.397). There were no effects of G1 infusion on velocity in the absence (Figure 5.6D, unpaired t
test, P=0.284) or presence of a social target (Figure 5.6H, unpaired t test, P=0.869). There was no
effect of G1 infusion on the time spent in the outer zone in the absence (Figure 5.6E, unpaired t
test, P=0.461) and presence of a social target (Figure 5.6I, unpaired t test, P=0.349).
Discussion
The results of the ICI infusion experiment suggest that estrogen signaling is involved in
behavioral susceptibility to stress. Infusion of ICI prior to AVSS results in a reduction in social
interaction time in females that have received both ICI infusions and AVSS, but not in females
that received AVSS alone, or ICI alone (Figure 5.2G). However, since ICI is a promiscuous
drug, meaning it has antagonist effects at ERα, ERβ, and Gq-mER, and agonist effects at GPER,
the results of this experiment are difficult to interpret.
Since ERβ knockout mice display an anxiogenic phenotype, and the expression pattern of
ERβ in a subset of VTA dopamine neurons, I hypothesized that ERβ is involved in the
behavioral response to stress (Walf et al., 2009). However, inhibition of ERβ by infusing the
ERβ specific antagonist, PHTPP, into the VTA did not replicate the reduction in social
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interaction. However, PHTPP significantly increased locomotion both while the drug was
onboard (Figure 5.5D and H) as well as one day later (Figure 5.4D). This is reminiscent of the
increase in locomotor activity after treatment with amphetamines and other drugs that increase
levels of dopamine (Antoniou et al., 1998).
Since ICI is also an agonist of GPER, I used the specific GPER agonist, G1, to test
whether the effects of ICI were due to activation of GPER by ICI. However, G1 infusion into the
VTA did not change any of the parameters I measured, regardless of whether the infusion was
prior to AVSS (Figure 5.6) or prior to social interaction (Figure 5.7). This suggests that the
effects of ICI on reducing social interaction were not due to activation of GPER.
Part 3: Discussion
The results in this chapter support my overall hypothesis that estrous cycle stage changes
the sensitivity of the dopamine system to external challenges. In this chapter, I showed that
estrous cycle has a significant impact on the behavioral response to stress. Moreover, I showed
that inhibiting estrogen signaling by infusing the non-specific ER antagonist, ICI, into the VTA
during AVSS increases the impact of stress in a similar manner as AVSS during estrus. The
specific ERβ antagonist, PHTPP, did not have any effects on social interaction after stress, nor
did the GPER agonist, G1.
There are several explanations for these results. First, ERα may be primarily involved in
the behavioral response to stress. Experiments using specific ERα antagonists infused into the
VTA would address this question.
Second, the effects of estrogen in the VTA may depend on synergistic inactivation of
both ERα and ERβ due to declining levels of estrogens, which are agonists for both receptors.
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Since ERα has a slightly higher binding affinity for estrogen then ERβ, and specific isoforms
have different binding affinities, activation of ERα happens at a lower concentration than ERβ.
Since it appears that both receptors are expressed in many dopamine neurons in the VTA, the
effects of the receptors generally oppose one another, it would be understandable that they act in
concert to coordinate the physiological response to E2. Experiments using cocktails of specific
ER agonists and antagonists at varying concentrations would be helpful to understand these
potential effects.
Third, if ERα antagonism does not mimic the effects of ICI on the reducing social
interaction time after AVSS, Gq-mER may be responsible. Currently, a specific antagonist for
Gq-mER has not been identified, so the specific effects of this receptor could not be tested. It
may be worthwhile to modify the behavioral paradigm to test whether the specific agonist, STX,
can reverse the behavioral response to AVSS during estrus.
However, both ICI and PHTPP infusions increase locomotion when the drug is onboard.
This increase in locomotion is similar to behaviors observed after injections of amphetamine,
cocaine, or other drugs that increase dopamine levels. Taken together with the results of chapter
4, section 2, where a small population of Ih+ neurons show a decrease in excitability, these
results seem counterintuitive. However, despite the use of I h as a marker for dopamine neurons,
some GABAergic neurons do express Ih (Miranda-Barrientos et al., 2021, Margolis et al., 2006).
It is possible that inhibiting ER signaling reduces firing in GABAergic neurons in the VTA,
leading to an increase in excitability in VTA dopamine neurons. Activation of VTA GABA
neurons reduces the excitability of dopamine neurons, which reduces dopamine release in the
NAc (van Zessen et al., 2012). If ICI and PHTPP reduce the activity of GABA neurons, this
effect would be reversed, and more dopamine would be released in the NAc, leading to similar
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behavioral effects as drugs that increase dopamine levels. This would explain the observed
increase in locomotion that I observed with PHTPP application to the VTA of living mice.
Experiments using reporter lines for GABA and dopamine neurons would clarify the circuit-level
effects of estrogen signaling in the VTA.
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Figure 5.1 Estrous cycle influences the behavioral response to acute variable social stress A)
Experimental design. B) AVSS increases serum corticosterone (cort) levels in female mice (Oneway ANOA, F(6, 27) = 16.10, P<0.0001; multiple comparisons, compared to control, ** P<0.01,
***P<0.001, ****P<0.0001). C) Social interaction time is decreased 24 hours after AVSS
(unpaired t test, P=0.0021) D) Reduced social interaction is driven by females in estrus on the
day of AVSS (Two-way ANOVA, cycle x stress interaction, F(3, 48) = 3.019, P=0.0387, multiple
comparisons between stress and control for each cycle stage, ***P>0.001). E) Estrous cycle on
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the day of interaction has no effect on social interaction time (Two-way ANOVA, cycle x stress
interaction, F(3, 45) = 1.618, P=0.1984).
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Table 5.1: Drugs used in cannula infusion experiments and their concentrations
Drug
ICI 182,780

Receptor
ERα, ERβ, Gq-mER antagonist,
GPER agonist

PHTPP

ERβ antagonist

G1

GPER agonist

Concentration used
10µg/µL,
0.5µL infused per
hemisphere
1ng/µL,
0.5uL infused per
hemisphere
0.02µg/µL,
0.5uL infused per
hemisphere
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Figure 5.2 The effects of ICI infusion prior to AVSS on social interaction behavior A)
Experimental design. B) Sample traces showing location and velocity of the mouse in the
absence of a social target. C) Social interaction time was not different in the absence of a social
target (Two-way ANOVA, stress x drug interaction, F(1, 30) = 1.089, P=0.305). D) There was no
difference in velocity in the absence of a target (Two-way ANOVA, stress x drug interaction, F(1,
30)

= 0.764, P=0.389). E) There was no difference in the time spent in the outer zone in the

absence of a social target (Two-way ANOVA, stress x drug interaction, F(1, 30) = 1.73, P=0.198).
F) Sample trace showing location and velocity of the mouse in the presence of a social target G)
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In the presence of a social target, the time spent in the interaction zone was significantly reduced
in the AVSS/ICI group (Two-way ANOVA, stress x drug interaction, F(1, 30) = 6.92, P=0.0133).
H) Velocity in the presence of a social target was not changed by ICI infusion or AVSS (Twoway ANOVA, stress x drug interaction, F(1, 30) = 0.0451, P=0.833). I) Time in the outer zone was
not increased in animals that received ICI infusion and AVSS compared to animals that received
ICI infusion but no stress in the presence of a social target (Two-way ANOVA, stress x drug
interaction, F(1, 30) = 5.57, P=0.0250).
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Figure 5.The effects of ICI infusion on social interaction behavior. A) Experimental design. B)
Example traces of animal location and velocity in the absence of a social target. C) ICI infusion
did not change time spent in the social interaction zone in the absence of a social target
(Unpaired t test, P=0.1926). D) ICI infusion increased velocity in the absence of a social target
(Unpaired t test, P=0.0292). E) ICI infusion did not change the time spent in the outer zone in the
absence of a social target (Unpaired t test, P=0.4761) F) Example traces of animal location and
velocity in the presence of a social target. G) ICI infusion decreased the time spent in the social
interaction zone (Unpaired t test, P=0.0189). H) ICI infusion increased velocity in the presence
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of a social target (Unpaired t test, P=0.0004). I) ICI infusion did not change the time spent in the
outer zone in the presence of a social target (Unpaired t test, P=0.7492).
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Figure 5.4 The effects of PHTPP infusion prior to AVSS on social interaction behavior A)
Experimental design. B) Example traces of animal location and velocity in the absence of a
social target. C) There were no differences in any groups in time spent in the interaction in the
absence (Two-way ANOVA, stress x drug interaction, F(1, 16) = 0.00312, P=0.956). D) PHTPP
infusion increased the average velocity in control animals in the absence of a target (Two-way
ANOVA, stress x drug interaction, F(1, 16) = 5.35, P=0.0343). E) There was no effect of PHTPP
or stress on time spent in the outer zone in the absence of a social target (Two-way ANOVA,
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stress x drug interaction, F(1, 16) = 0.116, P=0.738) F) Example traces of animal location and
velocity in the presence of a social target. G) There were no differences in any groups in time
spent in the interaction zone in the presence of a social target (Two-way ANOVA, stress x drug
interaction, F(1, 16) = 0.489, P=0.495). H) There were no differences in the velocity of any groups
when a target was present (Two-way ANOVA, stress x drug interaction, F(1, 16) = 1.63, P=0.220).
I) There was no difference in any groups in the time spent in the outer zone in the presence of a
social target (Two-way ANOVA, stress x drug interaction, F(1, 16) = 0.314, P=0.581).
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Figure 5.5 The effects of PHTPP infusion on social interaction behavor A) Experimental design.
B) Example traces of animal location and velocity in the absence of a social target. C) Time in
the social interaction zone was increased with no target (Unpaired t test, P=0.0115). D) PHTPP
infusion increased velocity in the absence (Unpaired t test, P=0.0157). E) PHTPP decreased time
spent in the outer zone when to target was present (Unpaired t test, P=0.0488) F) Example traces
of animal location and velocity in the presence of a social target. G) Time in the social
interaction zone approached significance with a target present (Unpaired t test, P=0.0836). H)
PHTPP infusion increased velocity in the presence of a social target (Unpaired t test, P=0.0157).
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I) PHTPP had no effect on time spent in the outer zone when a target was present (Unpaired t
test, P=0.296).
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Figure 5.6 The effects of G1 infusion prior to AVSS on social interaction behavior. A)
Experimental design. B) Example traces of animal location and velocity in the absence of a
social target. C) G1 infusion prior to AVSS does not affect the time spent in the social interaction
zone in the absence of a social target (Two-way ANOVA, stress x drug interaction, F(1, 15) =
2.547, P=0.131). D) G1 infusion does not affect velocity in the absence of a social target (Twoway ANOVA, stress x drug interaction, F(1, 15) = 0.466, P=0.506) E) G1 infusion does not affect
the time spent in the outer zone in the absence of a social target (Two-way ANOVA, stress x
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drug interaction, F(1, 15) = 1.93, P=0.185). F) Example traces of animal location and velocity in
the absence of a social target. G) G1 infusion prior to AVSS does not affect the time spent in the
social interaction zone in the presence of a social target (Two-way ANOVA, stress x drug
interaction, F(1, 15) = 0.921, P=0.352). H) G1 infusion does not affect velocity in the presence of a
social target (Two-way ANOVA, stress x drug interaction, F(1, 15) = 0.000450, P=0.983). I) G1
infusion does not affect time in the outer zone in the presence of a social target (Two-way
ANOVA, stress x drug interaction, F(1, 15) = 0.4378, P=0.518).
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Figure 5.7 The effects of G1 infusion on social interaction behavior. A) Experimental design B)
Example traces of animal location and velocity in the absence of a social target. C) G1 infusion
does not change social interaction in the absence (Unpaired t test, P=0.612) D) G1 infusion does
not affect velocity in the absence of a social target (Unpaired t test, P=0.284) E) G1 infusion
does not affect the time spent in the outer zone in the absence of a social target (Unpaired t test,
P=0.461). F) Example traces of animal location and velocity in the presence of a social target. G)
G1 infusion does not change social interaction in the presence of a social target (Unpaired t test,
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0.397) H) G1 infusion does not affect velocity in the presence of a social target (Unpaired t test,
P=0.869). I) G2 infusion does not affect velocity in presence of a social target (Unpaired t test,
P=0.349).
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Chapter 6: General Discussion
Part 1: Summary of findings
This dissertation presents data on previously unexplored interactions between estrogen
signaling, dopamine neuron physiology in the VTA, and stress susceptibility in female mice. The
data shows that dopamine neurons in the VTA respond to the estrous cycle, express ERs, and are
modulated by estrogen signaling to produce behavioral changes in response to a stressful
stimulus. My working hypothesis is that an interaction between stress and estrogen signaling that
converges in the VTA to produce different behavioral effects of stress in female mice, depending
on the circulating levels of sex steroid hormones.
In chapter 3, I present evidence that dopamine neuron activity is influenced by the estrous
cycle (Table 6.1). I show that spontaneous dopamine activity does not change significantly
across the estrous cycle, but during estrus there is a significant increase in intrinsic excitability in
a subpopulation of dopamine neurons. This is consistent with observations from the literature
that tonic dopamine release is relatively unaffected by estrous cycle, but phasic dopamine release
is enhanced during estrus (Becker and Cha, 1989; Becker 1990; Calipari, Juarez et al., 2017).
These changes are likely driven by changes in the conductance of ion channels, such as
potassium channels. Indeed, I observed a significant increase in potassium currents during
diestrus and metestrus, when intrinsic excitability was very low. Interestingly, during diestrus, a
rapidly inactivating potassium current was primarily increased, whereas during metestrus a
sustained, non-inactivating potassium current was increased. This likely results in different
physiological responses to repeated synaptic inputs. In this chapter I also show that a
subpopulation of dopamine neurons respond to the estrous cycle with an increase in intrinsic
excitability. By comparing high excitability neurons from animals that were in estrus at the time
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of recording to both low excitability neurons and neurons from animals that were in diestrus at
the time of recording, I show that many intrinsic properties of high excitability neurons lie within
the range of the intrinsic properties of neurons recorded during diestrus but are distinct from low
excitability neurons recorded during estrus. In other words, it appears that the intrinsic properties
of high excitability may be a marker for neurons that are sensitive to the estrous cycle. The
results of this chapter are the first evidence that hormone fluctuations due to the estrous cycle act
directly on dopamine neurons to modulate their intrinsic physiology.
In chapter 4, I show that estrogen signaling is involved in modulating the behavior of
dopamine neurons in the VTA in female mice (Table 6.2). Interestingly, at different points of the
estrous cycle, incubation with estrogen has opposite effects: during proestrus and estrus, estrogen
incubation decreases the intrinsic excitability, whereas during metestrus estrogen incubation
dramatically increases intrinsic excitability. These findings suggest that other steroid hormones
are involved in modulating the physiology of dopamine neurons across the estrous cycle. This is
supported by the observation some of the effects of progesterone infusion into the VTA require
estrogen priming (Frye et al., 2014). In this chapter I also show that potassium current is
unaffected by estrogen signaling in all stages of the estrous cycle except during metestrus, when
estrogen incubation increases both peak and sustained currents. This suggests that estrogen
incubation acts to decrease intrinsic excitability during proestrus and estrus through a different
mechanism, since no changes were observed in potassium currents. In some cases, however, an
increase in potassium current may lead to an increase in intrinsic excitability when the increase
in potassium current allows for the cell to repolarize faster after an action potential. This is one
explanation for the increase in excitability observed after estrogen incubation during metestrus.

97

The results of this chapter show that estrogen signaling acts across the estrous cycle to modify
the physiology of dopamine neurons.
In chapter 5, I show that estrogen signaling modulates the behavioral response to stress
(Table 6.3). Infusion of ICI, an antagonist of ERα, ERβ, and Gq-mER, and an agonist of GPER,
directly into the VTA prior to AVSS caused a significant reduction in social interaction one day
later in the group that received both the infusion and the stress. This suggests that estrogen
signaling works in combination with stress to decrease social interaction behavior. Since social
interaction is considered a measure of depression-like behavior in mice, the results of this
behavioral experiment suggest that estrogen signaling may contribute to susceptibility to
depression.
The ERβ-specific antagonist PHTPP and the GPER-specific agonist G1 both failed to
replicate this reduction in social interaction. This suggests that the effects of ICI and stress on
reducing social interaction act though either ERα or Gq-mER. Future experiments will use ERαand Gq-mER specific pharmacology to address the receptor identity of this phenomenon.
Interestingly, ICI also increases locomotion during the social interaction test when the drug is
onboard, an effect replicated by the infusion of PHTPP. This increase in locomotor behavior is
reminiscent of increases in locomotor behavior due to psychostimulant injections and suggests
that dopamine release is increased by ERβ inhibition. This supports earlier observations that
estrogen signaling works in the VTA through different mechanisms to affect different
subpopulations of dopamine neurons.
Contribution to the field and next steps
Cell-type specificity: In this dissertation, I showed that a subpopulation of dopamine
neurons responds to the estrous cycle and to estrogen signaling. Given the diversity of
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dopaminergic neurons in the VTA, there are several experimental directions that should be
followed up on based on my results. The first question addresses the identity of the population of
neurons that have high excitability during estrus, identified in chapter 3. Based on the percentage
of high excitability neurons and the percentage of ERβ+/TH+ neurons identified in figure 3.1,
the most likely candidate for a marker for responder neurons is ERβ. ERβ-eGFP positive cells
are readily identifiable for slice electrophysiology and could be used to replicate the findings
from chapter 3 and 4 (Milner et al., 2021). Moreover, by using retrograding viral injections, the
projection identities of these neurons could be traced to better understand the physiological role
of estrogen signaling in modulating specific dopamine projections. This would be particularly
valuable in the context of stress susceptibility and resilience, since PFC projecting neurons have
a different role in the behavioral response to stress compared to NAc projecting neurons
(Chaudhury et al., 2013).
Many drugs that modulate estrogen signaling are promiscuous at higher concentrations,
which necessitates many controls to induce interpretable results. Moreover, the effects of these
drugs may be excitatory or inhibitory depending on the molecular machinery present. One
alternative strategy to explore the role of ER+ cell populations would be to use one of several
ER-Cre lines to drive the expression of different genetic tools in the ER+ cells in the VTA
(Cacioppo et al., 2016; Park et al., 2017). Using this approach, in combination with Cre-driven
expression of light-sensitive ion channels, optogenetic inhibition or excitation of ERα+ and
ERβ+ cells could give a better understanding of the role of this specific population of neurons.
Care should be exercised in designing this experiment with the proper control groups, given the
recent finding that DAT-Cre mice, a mouse line commonly used to specifically target dopamine
neurons, behavioral effects of the expression of Cre in dopamine neurons, likely due to
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perturbations of the dopamine system (Costa et al., 2021). Interestingly, the behavioral effects of
these perturbations are sex-specific, yet more evidence for sex differences in the dopamine
system.
Synaptic signaling: This dissertation covers the changes in intrinsic properties of
dopamine neurons, leaving open further experiments investigating changes in synaptic behavior.
Many non-dopaminergic cells in the VTA express ERβ (Figure 3.1). These are likely
GABAergic interneurons. Estrogen signaling has been shown to modify expression of GABArelated genes (Herbison, 1997). G-protein coupled inwardly rectifying potassium (GIRK)
channels are inwardly rectifying K+ channels that are G-protein gated. These channels are key
regulators of resting membrane potential and cellular excitability in the brain. GIRK channels are
activated by type 2 dopamine receptors, resulting in hyperpolarization. GIRK channels in the
hypothalamus are regulated by estrogen. Moreover, the Gq-mER specific agonist, STX rapidly
activates GIRK channels in dopamine neurons in GABA, dopamine, and POMC neurons in the
hypothalamus (Qiu et al., 2003).
Additionally, estrogen signaling is well known to modulate, and even activate
metabotropic glutamate receptors (mGluRs). mGluRs are receptors for the excitatory
neurotransmitter, glutamate, that activate second messenger systems rather than ion channels.
These second messenger systems, in turn, modulate downstream targets that may modulate ion
channel conductance, change the transcription of gene targets. In dopamine neurons in the VTA,
mGluR activation enhances burst firing patterns (Zheng and Johnson, 2002). mGluRs are also
implicated in long term depression caused by burst firing (Pignatelli and Bonci, 2015). GluR2 is
involved in burst firing induced long term depression (LTD) in the VTA (Mameli et al., 2007)
Estrogen acts on metabotropic glutamate receptors (mGluR) through interaction with membrane100

associated ERs, and through ER independent mechanisms. (Meitzen and Mermelstein, 2011).
This means that estrogens can directly activate mGluRs. There are several different types of
mGluRs, which have different downstream effects. Indeed, mGluR activation by estrogens can
result in CREB phosphorylation, which changes the expression of CREB gene targets (GroveStrawser et al., 2010). Additionally, both ERα and ERβ interact with group II mGluRs to reduce
L-type calcium channel activity (Grove-Strawser et al., 2010, Mermelstein et al., 1996).
Dopamine release in the striatum has been known to fluctuate across the estrous cycle in
females for over 30 years (Becker and Cha, 1989). These fluctuations have been linked to
changes in drug seeking behaviors across the estrous cycle in females, and menstrual cycle in
women. Recently, using voltammetry to measure dopamine release and reuptake, dopamine
release in the NAc has been shown to change across the estrous cycle, and the kinetics of
reuptake by the dopamine transporter (DAT) changes corresponding to changes in the levels of
serum estrogen (Calipari, Juarez et al. 2018). Dopamine release within the VTA has a regulatory
effect on dopamine neuron activity (Ford, 2014). However, to date, changes in dopamine release
in the VTA across the estrous cycle has not been explored.
Identifying the roles of ERα and Gq-mER: Since ICI, an antagonist of ERα, ERβ, and GqmER, and an agonist of GPER, induces powerful behavioral changes in response to stress, but
the ERβ-specific antagonist PHTPP and the GPER-specific agonist G1 do not induce the same
response, a different ER may be responsible for the reduction in social interaction. ERα and GqmER are both inhibited by ICI. Repeating the experiments in chapter 5 with the ERα specific
antagonist MPP will clarify whether ERα is responsible for the reduction in social interaction
after stress. If ERα inhibition with MPP does not produce a reduction in social interaction in
combination with AVSS, Gq-mER inhibition is likely the ER that drives this response. Since a
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specific Gq-mER antagonist has not yet been identified, pharmacological manipulations using
STX to protect against a decrease in social interaction could be used to reveal the contribution of
this receptor. Likely, given the presence of multiple estrogen receptors in the VTA, it is possible
they are required to act together or at different time scales to modify behavior. This will be
further investigated with combinatorial activation and inactivation of the different ER types.
Part 2: Broader implications of differences across the estrous cycle
Broadly, the implications for steroid hormone modulation of dopamine neurons in the
VTA could influence our understanding of how the dopamine system works. The VTA which
serves as an integration point for reward-related behaviors, determination of salience of external
stimuli, and affective behaviors may be more highly driven by sex and estrous cycle dependent
internal hormonal signals than previously thought.
The findings in this dissertation support the emerging idea that male and female brains
share overlapping but distinct mechanisms. In the behavioral response to stress, male and female
behavior is different, where females show an increased sensitivity to stress compared to males.
This dissertation does not directly compare male and female behavior, but previous research
suggests that the behavioral response may be similar, but the underlying physiology is different.
The ventral tegmental area is a target for the development of many different drugs for
treating disorders such as depression, and drug abuse. Typically, pharmaceutical drug
development has focused on the male brain as the “default” and does not consider steroid
signaling (Shansky, 2019). This dissertation suggests that not only is steroid signaling important
for the behavioral response to stress but is a potential target for developing novel pharmaceutical
treatments for dopamine-related disorders, particularly in women.
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In addition to pharmaceutical interventions, the results of this dissertation suggest that
behavioral interventions for depression and drug abuse may benefit from coordination with
hormonal cycles in people who experience them.
Future directions
Modulation of estrogen signaling: While estrogen signaling serves as a modulator of
dopamine activity, the estrogen signaling system itself is the target of signaling processes that
may change the intensity of estrogen sensitivity, or the levels of estrogen available to dopamine
neurons in the VTA.
Aromatase, the enzyme that produces estrogen from testosterone, is modulated by social
behaviors in birds and in rodents. This question also involves the role of estrogen signaling in the
VTA of males. Figure 3.1 shows similar expression patterns of ERβ between males and females.
Aromatase, the enzyme that converts androgens to estrogens, is expressed in brain tissue,
suggesting that estrogens are synthesized locally either from circulating androgens, or from the
precursor cholesterol. These enzymes exist in both males and females and are potentially a
source of modulation. Aromatase plays an important role the medial preoptic area of rodents, a
region critical for social behaviors (Garcia-Segura, 2008). In birds, estrogens and other
neurosteroids are critical components of social interactions and fluctuate rapidly in response to a
social target (Remage-Healey et al., 2008). Aromatase mRNA and enzymatic activity was
detected in the midbrain of adolescent and prenatal rats, although neither were detected in the
midbrain of adult rats (Raab et al., 1995). The presence of ERβ expression in males, however,
suggests local estrogens are synthesized in the VTA, and more sensitive techniques such as RTqPCR may reveal the presence of low copy numbers of aromatase mRNA. the role in modulating
social behavior, and whether there is a modulatory role of aromatase in both males and females.
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Another source of potential modulation of the estrogen signaling system comes from the
expression patterns of ERs. There is evidence that ER expression changes depending on external
conditions, such as food and bedding type, presumably because of exposure to environmental
estrogens (Villalon Landeros et al., 2012). ERα and ERβ also express multiple splice variants, as
well as form heterodimers with each other. These variants may cause the receptor to lose
functionality, be constitutively active, or target different estrogen response elements, causing
different effects on neuronal physiology upon estrogen binding (Rettberg et al., 2014; Mott and
Pak, 2012). More research using methods that can detect mRNA splice variants would be useful
to understand which specific splice variant is expressed in the VTA, and its role in modulating
neuronal excitability.
Role of other steroid hormones: In this dissertation, I dissect out the role of estrogen
signaling in the VTA to isolate its contributions to the changes I observed across the estrous
cycle. However, the results suggest that other steroid hormones are involved in modulating the
response to estrogen, as well as the response to stress.
Progesterone signaling is a powerful modulator of neuronal activity. Activation of
progesterone receptors, like ERs, changes transcription of gene targets. Like estrogen signaling,
progesterone acts through both gene transcription and more rapid, “non-genomic” pathways.
There is considerable evidence that there is considerable crosstalk between estrogen and
progesterone signaling pathways (Diaz Brinton et al., 2008). Moreover, the progesterone
metabolite, allopregnanolone, is a positive allosteric modulator of GABA A receptors and has
been implicated in mood disorders such as postpartum depression and PMDD (Backstrom et al.,
2014; Meltzer-Brody and Kanes, 2020). Systemic allopregnanolone injections increases the tonic
release of dopamine in the NAc and amplifies the dopaminergic response to a morphine injection
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but decreases phasic dopamine release (Rouge-Pont et al., 2002; Dornellas et al., 2021).
However, the physiological effects of progesterone and allopregnanolone on the physiology of
dopamine neurons and local circuitry in the VTA have not been explored.
Androgens, such as testosterone, also likely modulate the behavior of VTA dopamine
neurons. Androgen receptors have been colocalized with TH+ cells in the VTA (Kritzer, 1997).
Androgen signaling has been linked to social behaviors in males, especially in the context of
competition and aggression. Androgen receptor expression is enhanced in the VTA in males who
win in aggressive encounters (Fuxjager et al., 2010). However, like estrogen signaling, the role
of androgen signaling in modulating the physiology of dopamine neurons is understudied.
Motivation and reward: In this dissertation I used the behavioral response to stress to
explore the role of steroid hormones in modulating the dopamine system. However, the
dopamine system is famously involved in motivation and reward, with rewarding stimuli
eliciting an increase in activity of VTA dopamine neurons. Based on my findings, I hypothesize
that estrogen signaling is also involved in modulating the intensity of rewarding stimuli. This is
supported by the findings that estrogen signaling modulates sensitivity to drugs of abuse
(Calipari, Juarez et al. 2018). Moreover, in humans and rodents, hormone changes due to
pregnancy cause profound changes in motivated behaviors (Rincon-Cortes and Grace, 2020).
Experiments exploring the role of steroid hormones in influencing motivated behaviors would
provide more insight into the modulation of dopamine neurons by estrogen signaling.
Conclusion
Characterization of dopamine neuron activity at different internal states, such as across
the estrous cycle, advances our understanding of the role of global signals on network dynamics.
Further, I established a functional connection between estrogen levels and dopamine neuron
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activity which underly individual differences in the behavioral response to the same event.
Overall, the continued study of estrogen signaling will provide insights of general interest that
concern cellular mechanisms, organization, and dynamics of neural circuitry throughout multiple
estrogen sensing brain regions.
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Table 6.1 Summary of physiological changes across the estrous cycle

Estrous
cycle stage

Intrinsic
Excitability

Spontaneous
Firing Rate

Peak potassium
current

Sustained
potassium
current

Proestrus
Estrus
Metestrus
Diestrus

↔
↑
↔
↔

↔
↔
↔
↔

↔
↔
↔
↑

↔
↔
↑
↔
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Table 6.2 Summary of the effects of estrogen incubation across the estrous cycle

Estrous Intrinsic
cycle stage Excitability
Proestrus
Estrus
Metestrus
Diestrus

↓
↓
↑
↔

Spontaneous
Firing Rate

Peak potassium
current

Sustained
potassium
current

Decreased variability
↔
↔
↔

↔
↔
↑
↔

↔
↔
↑
↔
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Table 6.3 Summary of behavioral findings

Drug

Social interaction

Velocity

Thigmotaxis

ICI 182, 780

Reduced after stress,
When drug is onboard

Increased when drug is
onboard

No change

Increased investigation of
novel object when drug is
onboard

Increased when drug is
onboard and one day later

Reduced when drug is
onboard

No change

No change

No change

(ERα, ERβ, Gq-mER
antagonist, GPER agonist)

PHTPP
(ERβ antagonist)

G1
(GPER agonist)
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